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Successful marketing strategies for clinical validation packages not only help laboratories 
increase the accuracy and efficiency of testing, but also facilitate clinical quality 
awareness and collaboration. False diagnosis and inefficiency in healthcare can be costly, 
and managers in diagnostic instrument manufacturing organizations need strategies to 
promote validation packages to help laboratories reduce errors leading to inappropriate 
treatment. The purpose of this single case study was to explore strategies business 
development managers use to integrate dynamic capabilities for marketing instrument 
validation packages aimed to increase clinical laboratory quality and test accuracy. The 
conceptual framework was Teece’s concept of dynamic capabilities. The data collection 
process involved semistructured interviews with 4 business development managers from 
a diagnostic instrument manufacturing organization in the western United States who had 
successfully marketed validation packages. Analysis of the audio recordings, notes from 
the interviews, and marketing flyers yielded 1 overarching theme, collaboration of cross-
functional teams, and 4 subthemes: integration, effectiveness, partnership, and 
profitability. The results suggested dynamic capabilities created value for validation 
packages, differentiated the products and services from those from the competitors, and 
increased customer satisfaction and profitability. The implications for positive social 
change include the potential to promote validation packages to clinical laboratories and 
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Section 1: Foundation of the Study  
Americans spent more than one-third of their large annual healthcare expenditure 
of over $3 trillion in 2012 on outpatient laboratory tests (Hicks, 2015). The costs 
associated with the tests, ordering of the incorrect tests, misuse of the tests, and poor 
quality of the tests not only can be financially burdensome to patients (Hicks, 2015; Luga 
& McGuire, 2014), but also can lead to delayed or incorrect treatments (Freeman, 2015). 
Accurate and high-quality diagnostic processes have the potential to minimize overuse in 
healthcare spending and improve care delivery. 
In changing environments, dynamic capabilities allow organizations to integrate, 
build, and reconfigure internal and external resources to gain a competitive advantage 
(Teece, 2012). The scrutiny on laboratory quality has increased, and the compliance 
demands from clinical regulatory agencies have impacted the diagnostic laboratory 
industry (McMillan, 2016). Because regulatory environments are constantly changing to 
address new technologies and quality demands, organizations in the healthcare industry 
can use dynamic capabilities to gain productivity and profits.  
The next generation sequencing (NGS) market is relatively new in the clinical 
diagnostic industry (Cummings, Peters, Lacroix, Andre, & Lackner, 2016). Many NGS 
diagnostic instrument manufacturing organizations offer instrument validation packages 
to their customers in clinical laboratories to help them improve and maintain laboratory 
quality and regulatory compliance. To increase competitive advantage and profitability, 
business development managers should explore good strategies for integrating dynamic 
capabilities when developing and marketing NGS instrument validation packages. In this 
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study, my goal was to contribute insight about the strategies business development 
managers used to integrate dynamic capabilities in marketing. My focus was NGS 
instrument manufacturing organizations in the western United States that offered 
validation packages to their clinical customers to improve laboratory quality. 
Background of the Problem 
The total national health expenditure in the United States was $3 trillion in 2014 
(Centers for Disease Control and Prevention, 2015). The high expenditure on healthcare 
resources and the progress in medical diagnostics innovation has led to scrutiny by 
governing authorities and healthcare agencies (Chen & Scheld, 2014; Panagiotou, 2013). 
However, in clinical and laboratory testing, there are mandatory standards and 
regulations for the procedures and documentation to account for the quality assurance 
(Lester, Harr, Rishniw, & Pion, 2013). Many diagnostic instrument manufacturing 
organizations offer instrument validation packages designed to help laboratories maintain 
quality records.  
Over-diagnosis or incorrect diagnosis of cancer in the United States can lead 
patients into unnecessary treatments. Unnecessary treatments have cost $100 billion a 
year in chemotherapy revenues (Esserman, Thompson, & Reid, 2013). Laboratory staff 
applying quality assurance methods such as analytical validations, a type of compliance 
services, are more likely to avoid incorrect diagnoses (Fitzgibbons et al., 2014); however, 
there is a lack of studies on how to market validation services aimed to increase 
laboratory quality in the United States (Smith, 2010). In this single case study, I explored 
how a diagnostic instrument manufacturing organization marketed the validation 
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packages aimed to increase laboratory quality assurance and minimize incorrect 
diagnoses. The study included interviews with four business development managers 
currently employed in an NGS oncology diagnostic instrument manufacturing 
organization located in the western United States. The purpose of this qualitative single 
case study was to explore strategies business development managers used to integrate 
dynamic capabilities for marketing instrument validation packages aimed to increase 
clinical laboratory quality and test accuracy. 
Problem Statement 
The inconsistent quality of oncology diagnostic laboratories can cause systematic 
incorrect diagnoses of cancer, leading patients into unnecessary treatments that cost $210 
billion a year in chemotherapy in the United States (Hicks, 2015). Problems with 
diagnostic tests accounted for 47.4% of diagnostic errors in primary care settings, 
resulting in false positive and false negative outcomes (Plebani, 2017). The general 
business problem was that incorrect diagnosis of cancer frequently happens in the United 
States, especially when the clinical laboratories do not meet the standards of regulatory 
compliance. The specific business problem was that some managers in oncology 
diagnostic instrument manufacturing organizations lacked marketing strategies to 
promote instrument validation packages for increasing the accuracy of oncology 
laboratory test results. 
Purpose Statement 
The purpose of this qualitative single case study was to explore what marketing 
strategies successful managers in a diagnostic instrument manufacturing organization 
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used to promote sales of validation packages for increasing the accuracy of oncology 
laboratory test results. The targeted population consisted of managers in an NGS 
instrument manufacturing organization located in the western United States who had 
successfully marketed validation packages. The population was appropriate for this study 
because research suggested compliance services lead to resource-efficient diagnoses 
(Gagan & Van Allen, 2015) and most in vitro diagnostics had been certified based on the 
manufacturers’ assessment (Enzmann, Meyer, & Broich, 2016). The reduction of testing 
errors and decrease in inappropriate treatment would enhance the quality of healthcare for 
patients (Long-Mira, Washetine, & Hofman, 2016). The implication for positive social 
change includes positive improvement for patient care. 
Nature of the Study 
The design for this qualitative single case study involved interviews with business 
development managers in an NGS instrument manufacturer located in the western United 
States who had successfully marketed validation packages. I considered three methods 
for this research study: qualitative, quantitative, and mixed methods. The qualitative 
research method allows researchers to gain insights into why people engage certain 
behaviors (Rosenthal, 2016), which is the most common method of data collection used 
in healthcare research (Leung, 2015). I chose the qualitative method for this study 
because it was most suitable for exploring narratives, meanings, and behaviors. The 
quantitative method was not appropriate for this study because this approach involves 
numerical data and statistical analysis (Hafford-Letchfield, 2014), and the purpose of this 
study did not require numerical data design or hypothesis testing. The mixed method 
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approach involves both a qualitative and quantitative component (Creswell & Poth, 
2017), but because there was no quantitative component to the study, mixed methods was 
not appropriate. 
I considered four qualitative research designs: narrative research, phenomenology, 
ethnography, and case study. Narrative design begins with the experiences of individuals 
that are expressed in lived or told stories and provides a means to analyze the stories 
(Lewis, 2015); phenomenology includes the explanation of the meaning of common lived 
experiences for research participants (Yin, 2014); and ethnography includes the 
description and interpretation of the shared and learned patterns of values, behaviors, 
beliefs, and language of a culture-sharing group (Creswell & Poth, 2017). However, these 
approaches were not suitable for this study for identifying and exploring strategies to 
promote products. A case study is used to explore an issue through analysis and in-depth 
description of a bounded system (Creswell & Poth, 2017). The case study is the most 
appropriate design for a study looking to define strategies to address a problem. I selected 
the single case study method because the focus of this research was to understand 
successful marketing elements. The study allowed me to explore the marketing strategies 
in instrument validation packages for increasing oncology laboratory testing accuracy.  
Research Question  
What marketing strategies do managers in oncology diagnostic instrument 
manufacturing organizations use to promote instrument validation packages for 




1. Describe the validation packages that you offer for your NGS platforms.  
2. Describe the target customer base for the compliance products that you offer.  
3. What are your marketing strategies for the compliance products? 
4. What elements of the validation package provide a competitive advantage to 
your company? 
5. How often does your organization revise the compliance service package to 
reflect customer needs and attract target market? 
6. How does your organization evaluate the distribution channels for the 
validation packages? 
7. How does your organization determine the effectiveness of your marketing 
strategies? 
8. What additional information can you share regarding marketing strategies for 
promoting sales of instrument validation products? 
Conceptual Framework 
The objective of this study was to explore some managers’ lack of marketing 
strategies to promote instrument validation packages aimed to increase oncology 
laboratory quality in oncology diagnostic instrument manufacturing organizations. It is 
crucial to understand the regulatory needs in clinical laboratory to create and market a 
product that is valuable to the customers for businesses that desire to improve sales and 
create a positive brand reputation (Dwesar & Rao, 2014). The dynamic capabilities 
theory (Teece, Pisano, & Shuen, 1997) was the conceptual framework for this study 
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because dynamic capabilities determine organizations’ ability to build, integrate, and 
realign internal and external resources to address changing business environments 
(Teece, 2010).  
Dynamic capabilities refer to organizations’ capability to succeed as a result of 
using accessible resources during rapidly changing environments (Teece, 2010). These 
capabilities determine the speed and degree to which organizations align or realign their 
resources to meet the changing requirements and opportunities (Teece et al., 1990, 1997). 
Due to the expansion of global clinical networks and rapid competitive responses, 
business owners need to develop and maintain asset alignment capabilities and 
collaborate with others to combine resources to deliver value to customers (Teece, 2012). 
I used the dynamic capabilities theory to help understand how successful managers in 
oncology diagnostic instrument manufacturing organizations market products and 
services for adding value to their compliance services in response to constantly changing 
regulatory environments. These organizations’ ability to succeed was dependent on their 
ability to adapt to a changing environment and meeting new demands. 
Operational Definitions 
Analytical qualification: Analytical qualification is a documented verification, 
which includes an accuracy study to evaluate concordance between results obtained by 
the newly designed assay and analyzed by another method or laboratory (Grosu et al., 
2014). 
In vitro diagnostic products: In vitro diagnostics are reagents, instruments, and 
systems intended for use in diagnosis of disease or other conditions, including a 
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determination of the state of health to cure, mitigate, treat, or prevent disease (U.S. Food 
and Drug Administration, 2014). 
Installation qualification: Installation qualification is a documented performance 
test to show that the equipment is correctly installed and operates in accordance with 
established specifications (Sandhya et al., 2015). 
Next generation sequencing (NGS): NGS is the technology to sequence millions 
of short fragments of DNA in parallel instead of one DNA fragment at a time (Aziz et al., 
2015). 
Operational qualification: Operational qualification is a documented verification 
to show that the system or subsystem performs as intended (Sandhya et al., 2015). 
Performance qualification: Performance qualification is a documented 
verification that the system consistently operates within predetermined acceptance 
criteria (Sandhya et al., 2015). 
Assumptions, Limitations, and Delimitations 
Assumptions 
Assumptions are beliefs that the researcher takes to be true without proof 
(Marshall & Rossman, 2016). Interviewing is one of the most common methods of 
gathering qualitative data in research and the findings from the interviews are dependent 
on truthfulness (Bullock, 2016). The validity of qualitative studies often depends on the 
participants’ truthfulness, credibility, and trustworthiness (Twining, 2017). I anticipated 
that the managers who participated in this doctoral study answered honestly. In addition, 
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I assumed that the participants understood the scope of this study and were willing to 
provide information necessary to contribute to this research. 
Limitations 
Limitations are constraints beyond the researcher’s control that can impact the 
study outcome (Marshall & Rossman, 2016). It is important to clarify the limitations in 
qualitative case studies. Many case studies have been performed within a specific 
context, which contributes to a misconception about applications in other research areas 
(Sangster-Gormley, 2013). The primary limitation of the study was what effects the 
relationship between the clinical laboratory and the compliance performance had on the 
success or failure of an accreditation or audit. If the laboratory managers opted to have 
the instrument manufacturers to perform compliance services, the results and 
documentation quality would rely on the manufacturer representative who performed the 
tests. However, a testing representative could skew the audit and accreditation results by 
poorly performing tests, and there was not a known methodology to screen for 
representatives’ ability to perform instrument qualifications and analytical validations 
during this study. This concern was noted during the interview; therefore, the discrepancy 
in representatives’ competence was included in this study. Future research should be 
done to determine if the instrument manufacturer’s representative’s ability to execute 
compliance services will impact the compliance package value. 
In addition to the relationship between clinical laboratories and the instrument 
manufacturing organization, there were two other limitations. First, the number of four 
participants was small. Second, business development managers participating in this 
10 
 
study were limited to the area of the western United States and only those who had 
demonstrated success in addressing strategies for marketing NGS compliance packages. 
Delimitations 
Delimitations are boundaries that the researcher institutes in the study to keep it 
manageable (Bhat, Gijo, & Jnanesh, 2014). The researcher sets the boundaries or 
delimitations for an exploratory single case study (Bouzon, Miguel, & Rodriguez, 2014). 
Local regulatory guidance and clinical requirements can vary (Vis & Huisman, 2016), but 
this study was performed on one NGS instrument manufacturer located in the western 
United States. The research effort included in-depth interviews with managers who had 
successfully marketed compliance services. For this study, the compliance services 
provided by the NGS instrument manufacturers referred to instrument installation 
qualification, operational qualification, performance qualification, and analytical 
validation. Having the three qualifications completed on clinical instruments not only 
keeps the laboratory in compliance but also improves the overall knowledge of the 
process (Agnihotri, Kaur, Kumar, & Chahal, 2013), while analytical validation 
guarantees that each step and activity throughout the total testing process is correctly 
performed to provide valuable results for medical decisions and effective patient care 
(Giuseppe et al., 2013).  
Significance of the Study 
The inconsistent quality of oncology diagnostic laboratories’ technicians can 
cause systematic incorrect diagnoses of cancer, leading patients into unnecessary 
treatments that cost $210 billion a year in chemotherapy in the United States (Hicks, 
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2015). Scholars have shown that good laboratory compliance can help avoid false 
diagnoses (Fitzgibbons et al., 2014). By adding value to these services, more laboratories’ 
owners could market the compliance packages aimed to increase laboratory quality. 
Contribution to Business Practice  
Equipment validation compliance assures that the workflow is developed, 
maintained, and operated as designed (Agnihotri et al., 2013). Through understanding the 
value proposition, managers at diagnostic instrument manufacturers can channel 
marketing resources that add value to instrument validation packages and ultimately 
increase sales. The growing scrutiny on diagnostic laboratory quality has increased the 
demand for testing instrument performance under their intended use (Ravell & 
Chandramohan, 2014). The contents, quality, price, and execution efficiency for the 
instrument validation packages are critical issues influencing sales. Dynamic capabilities 
allow organizations to integrate, build, and reconfigure resources to address the changing 
business environments (Teece, 2012). Through continuous integration and 
reconfiguration of internal and external resources, managers in NGS instrument 
manufacturers can offer best in class validation packages in response to the rapidly 
changing clinical regulatory environments while achieving sales goals. 
Implications for Social Change 
Diagnostic laboratory results are required for making a large portion of medical 
decisions (Peter et al., 2010). Studies, like one conducted in Canadian laboratories on the 
relationship between laboratory quality and patient safety, have shown that laboratories 
with a solid foundation in quality enhanced patient safety by preventing several care 
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issues (Allen, 2013). Accreditation and validation have the potential to improve the 
quality of healthcare for patients through the reduction of testing errors and decreases in 
inappropriate treatment (Peter et al., 2010). When instrument manufacturers proactively 
provide compliance assistance to clinical laboratories, staff are more likely to accept and 
follow through with meeting regulatory requirements. As a result, the quality of patient 
care should improve, and healthcare resources can be allocated more accurately and 
efficiently. 
A Review of the Professional and Academic Literature 
The goal of this study was to explore marketing strategies that successful 
managers used to promote oncology diagnostic instrument validation packages. These 
compliance packages included the production of documented verification to help clinical 
laboratories achieve accreditation and maintain quality practices (Acuna, Collino, & 
Chiabrando, 2015). Dwesar and Rao (2014) stated that to effectively design and market a 
product that is valuable to the customers, managers must have the desire to improve. The 
dynamic capabilities theory is the conceptual framework for this study because dynamic 
capabilities help determine organizations’ ability to build, integrate, and realign internal 
and external resources to address changing business environments (Teece, 2010). I used 
this theory to understand how successful managers in oncology diagnostic instrument 
manufacturing organizations marketed products and services to add value to their 
compliance services in response to constantly changing regulatory environments.  
I organized the literature review according to the following six themes: (a) 
healthcare spending, (b) diagnostic laboratory quality, (c) accreditation and regulations, 
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(d) instrument manufacturing organizations’ role, (e) dynamic capabilities and value in 
third-party validation services, and (f) resource-based theory. This review of literature 
consists of scholarly resources including peer-reviewed articles, books, and government 
reports. The roster includes 89 total references: 76 (85.4%) have a publishing date within 
5 years of 2018, the expected year of CAO approval; 85 (95.5%) of which are peer-
reviewed. I used the following databases to search for peer-reviewed articles applicable 
for my study: Google Scholar, Walden University Library, Science Direct, Emerald 
Management Journals, Management and Organizational Studies, EBSCOhost, and 
ProQuest. Within this study, I used the following search themes and terms: clinical 
diagnostic instruments, diagnostic laboratory quality, total quality system, healthcare 
spending, CLIA inspection, instrument qualification, NGS diagnostics, laboratory-
developed tests, medical device manufacturer, laboratory accreditation, dynamic 
capabilities, and resource-based view. 
Healthcare Spending 
Healthcare expenditure in the United States has been a large portion of the annual 
spending in gross domestic products. More than one-third of the U.S. annual expenditure 
was spent on outpatient laboratory tests such as routine diagnostic tests and oncology 
screening (Hicks, 2015); however, not all laboratory tests result in the patients’ best 
interests. The costs associated with the tests, ordering of incorrect tests, misuse of tests, 
and poor quality of tests not only can be financially burdensome to the patients (Hicks, 
2015; Luga & McGuire, 2014), but also can lead to delayed or incorrect treatments 
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(Freeman, 2015). Accurate and high-quality diagnostic processes have the potential to 
minimize unnecessary healthcare spending and improve care delivery. 
In 2010 the cost of healthcare in the United States exceeded $2.7 trillion, and up 
to 30% of spending was identified as wasteful (Luga & McGuire, 2014). Additionally, 
roughly one-third of the $2 trillion spent in the U.S. healthcare system has been linked to 
fraud, waste, and abuse (Thornto, Brinkhuis, Amrit, & Aly, 2015). Finally, the annual 
healthcare expenditure in the United States for laboratory tests was estimated at $65 
billion in 2012, with approximately $6.8 billion in unnecessary laboratory testing and 
procedures that did not improve patient care (Freedman, 2015). NGS sequencing has 
been incorporated rapidly to clinical laboratory testing, including detection of germline 
variants in inherited diseases and somatic variants in cancers (Lyon et al., 2015). The 
annual cost of cancer healthcare in the United States is expected to reach $158 billion in 
2020 (Young, 2015). Physicians are often unaware of the cost of tests and treatments, 
making it difficult to account for the financial impact (Hicks, 2015). Promoting 
laboratory quality to ensure that diagnostic tests are performed as efficiently as possible 
is a practical route to minimize healthcare cost and wasteful treatments. 
As healthcare expenditures continue to rise, the efficacy and efficiency associated 
with the costs are under scrutiny (Vijayasree et al., 2017). Laboratory managers face 
challenges in testing, including the ability to accurately, efficiently, and safely order and 
interpret diagnostic tests. To improve current laboratory testing situation, each laboratory 
test must be appropriately ordered, properly conducted, reported in a timely manner, 
correctly interpreted, and affect a decision for treatment of the patient. Human error by 
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technicians such as incorrect tests ordered by the physicians, failure of guideline 
implementation, and inappropriate laboratory use can contribute to poor testing 
(Freedman, 2015).  
There is a need for new strategies to address these challenges in laboratory 
quality. Manufacturers, regulatory agencies, and laboratories should all be involved in 
striving for laboratory quality measures that will lead to more cost- and resource-efficient 
testing (Zehnbauer et al., 2017). Additionally, Hicks (2015) stipulated that 78% of the 
physicians in the United States thought treatments should be solely devoted to patients’ 
best interests, regardless of the costs. This implies that strategies to curb overuse that are 
driven by a financial imperative are unlikely to result in meaningful changes. By focusing 
on laboratory quality measures, all stakeholders can improve care delivery while reducing 
unintended overuse (Hicks, 2015). For instance, Luga and McGuire (2014) suggested that 
to contain costs by reducing waste, it is necessary to improve the effectiveness of care 
delivered. The NGS instrument manufacturers designed helps the systems to meet 
diagnostic needs and address their intended use. Validating the system using the 
manufacturers’ established standards will ensure that the system is performing according 
to specifications and laboratory members are adhering to the clinical guidelines (Sandhya 
et al., 2015). Validating diagnostic instruments reduces the rate of poor test results from 
inconsistent instrument performance (Sandhya et al., 2015), which is helpful in 
minimizing retests and spending associated with subsequent actions. By focusing on 




Diagnostic Laboratory Quality 
Laboratory medicine plays a pivotal role in the provision of healthcare. The 
healthcare costs, treatment, and patient care are determined by the associated diagnosis 
from the interpretation of the clinical laboratory results. Although there are notable 
advances in laboratory diagnostics, a number of errors still exist that can lead to 
erroneous patient diagnosis and treatment. These errors are challenging to address 
because the scope of the testing process from accurate test ordering, appropriate sample 
handling, properly conducted protocols, timely result delivery, to correct interpretations 
(Freedman, 2015) leads to a complicated pathway that is prone to errors. Negative factors 
influencing test ordering by physicians, failure of guideline implementation, and 
inappropriate laboratory use can all contribute to poor testing. The rapid adoption of NGS 
in clinical testing complicates the matter as clinical NGS testing involves complex 
analytic wet bench processes and intensive bioinformatics analyses (Aziz et al., 2015). 
Ensuring all tests are conducted efficiently can not only reduce the processing costs, but 
also lead to meaningful results that will help deliver proper treatments to patients. 
Medical errors concerning diagnosis and clinical decision-making can contribute 
to poor outcomes, including delayed or missed diagnoses, mortality, and excessive costs. 
For example, Tehrani et al. (2013) performed a study on diagnosis-related claims from 
the National Practitioner Data Bank from 1986 to 2010 and found that the diagnostic 
errors reached 28.6% and accounted for the highest proportion of total payments at 
35.2%, with outcomes including death and permanent injury over 350,706 paid claims. 
Most error claims came from outpatient laboratory testing at 68.8%, and the sum of 
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diagnosis related payments was $38.8 billion (Tehrani et al., 2013). The findings from the 
study suggest that the public health burden of diagnostic errors is significant, and 
healthcare stakeholders should consider diagnostic safety an important health policy issue 
and a potential avenue to reduce annual spending.  
Other studies have also shown that healthcare overuse can cause financial harm, 
and quality measures to improve care delivery can be the solution for money saving 
(Hicks, 2015). The efficiency of appropriate test use on patient outcomes and on cost 
effectiveness across the whole patient pathway is the key to improve healthcare 
(Freedman, 2015). Lippi, Plebani, and Graber (2016) argued that quality in laboratory 
medicine should guarantee that each step and activity throughout the total testing process 
is correctly performed to provide valuable results for medical decisions and effective 
patient care. Scientists have observed a 10-fold reduction in the analytical error rate after 
laboratories undergoing improvements in both reliability and standardization of analytical 
techniques, reagents, and instrumentation (Giuseppe et al., 2013). Furthermore, 
advancement in information technology, quality control, and quality assurance methods 
can also help reduce diagnostic errors (Lippi et al., 2016). Clinical instrument validation 
packages targeting the improvement in laboratory quality have the potential to reduce 
errors, minimize retests, and increase healthcare cost savings (Vijayasree et al., 2017). 
Although diagnostic tests are often defined by their sensitivity, specificity, and 
ease of use, the actual clinical impact of such tests also depends on their availability and 
price (Schroeder, Elbireer, Jackson, & Amukele, 2015). This impact is especially obvious 
in resource-limited regions (Schroeder et al., 2015). For instance, a study conducted in 
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clinical laboratories in Kampala to measure the diagnostic test availability, test volumes, 
and pricing suggested that 50% of overall test availability was provided through private 
laboratories while only 36% from public laboratories (Schroeder et al., 2015). In addition, 
the price of the test was dependent on the test availability. The more common the 
diagnostic test is, the cheaper the average price (Schroeder et al., 2015). The test 
availability hinged upon whether the laboratory passed the regulatory inspection and 
obtained the authorization to perform the diagnostic test. This suggests that the overall 
laboratory quality can impact test prices.  
Singh, Meyer, and Thomas (2014) argued that diagnostic errors pose a threat to 
healthcare quality and safety, including outpatient diagnostic errors. There are many 
reasons why diagnostic errors are difficult to monitor: varying error definitions, the need 
to review data across multiple healthcare providers, and the need to review care settings 
over time (Singh et al., 2014). From monitoring unusual patterns of return visits and the 
lack of follow-up of abnormal clinical findings related to cancer, diagnostic errors can be 
confirmed through chart review (Singh et al., 2014). Singh et al. (2014) revealed in their 
study an annual rate of outpatient diagnostic errors of 5.08%, indicating that 
approximately 12 million adults in the United States encountered diagnostic errors every 
year. The costs associated with these diagnostic errors are significant and cause 
unnecessary financial burden (Hicks, 2015). 
The reduction of diagnostic testing errors and the improvement of laboratory 
quality contribute to not only cost-saving benefits, but also laboratory operating 
efficiency and advanced patient care. Abdallah (2014) argued that quality initiatives have 
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shown success in many healthcare organizations. Elbireer et al. (2013) also recognized 
the importance in clinical laboratory quality and the laboratories’ function in addressing 
the high rates of diseases and emphasized the benefits of using a standard baseline 
measure of quality such as the World Health Organization (WHO) Laboratory 
Strengthening Checklist. Elbireer et al. showed that although laboratories with higher 
testing volumes tended to be of higher quality compared to low volume laboratories, 
there is significant room for improvement in clinical laboratories in general. Elbireer et 
al. recommended three areas in which focused interventions could significantly improve 
laboratory quality at low or no additional cost: having work conducted only by clinically 
qualified staff, only accepting test volumes high enough to support staff competency, and 
obtaining accreditations to abide by clearly-defined quality standards. The improved 
laboratory quality should reduce the risk of error and harm (Lippi et al., 2016). 
Although many healthcare organizations that have recognized the significance in 
quality and patient care had success in quality initiative, some have continued to struggle 
in initiative implementation. Understanding drivers and challenges in quality initiative 
implementation from literature reviews and comparing them to current healthcare 
processes can help with proposing a framework that could lead to best implementation 
results (Abdallah, 2014; Al-Mutairi et al., 2016). The diagnostic testing laboratory’s 
ability to provide reliable results and operational logistics are often the focal points of 
clinical laboratory operation (Acuna et al., 2015). By obtaining laboratory accreditation, 
management ensures compliance and minimized instances of error. Additionally, Acuna 
et al. (2015) argued that technological developments and the modular installation of 
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automated equipment and robotics requires adaptation and new tools for designing and 
implementing internal and external quality control as well as quality assurance. Because 
the instrument manufacturers have designed and optimized the diagnostic equipment, it 
can be beneficial for laboratories to use their instrument validation offerings. Marketing 
strategies often improve the delivery of products (Kaleka & Morgan, 2017), which can be 
used to enable instrument manufacturing organizations to deliver valuable products 
aimed to enhance the quality in clinical laboratory operation. 
Diagnostic errors lead to missed opportunities to make a correct and timely 
diagnosis, causing patients harm. Therefore, it is important for clinical laboratories to 
focus on the quality of the entire testing process instead of just the analytical portion. The 
total testing process pertains to a number of phases of laboratory testing, from 
preexamination, examination, and postexamination activities (Adcock, Favaloro, & 
Lippi, 2016). Most laboratory errors occur in the preexamination phase, preventing 
clinical laboratories from delivering accurate and meaningful laboratory results (Adcock 
et al., 2016; Zaini, Dahlawi, & Siddiqi, 2016). In addition, extra-laboratory factors often 
cause a multitude of errors in the preexamination phase (Plebani et al., 2014; Sciacovelli, 
Aita, & Plebani, 2017). The preexamination phase activities are sample collection, 
handling, transportation, processing, and storage, which are often outside the control of 
the laboratories that performed the actual tests (Adcock et al., 2016). Having a clear and 
standardized quality system and using external quality assessment can help improve 
quality in the total testing process (Giuseppe et al., 2013). 
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Although striving for quality over the total testing process can minimize 
diagnostic errors, physicians’ interpretation of the test results can contribute to 
inaccuracies as well, leading to missed opportunities to make a correct and timely 
diagnosis (Al-Mutairi et al., 2016). Bari, Khan, and Rathore (2016) showed in their study 
that although 98.5% of the medical practitioners described some form of error, only 11% 
disclosed the error to the patients’ family. Even though the disclosure of error rate was 
low, many medical practitioners showed a positive change in their behavior and became 
more careful (Bari et al., 2016). Many of the instrument manufacturer-provided 
validation packages include customer trainings. Considering the often severe 
consequences caused by medical errors, the indirect value in these validation packages 
can be significant. 
The rapid development of new cancer treatments has shifted the focus of tumor 
evaluation in pathology toward molecular analysis. Diagnostic molecular pathology, 
which determines the molecular aberrations present in tumors for diagnostic, prognostic, 
or predictive purposes, has faced technological challenges due to the shifted focus. 
Laboratory staff members have to meet the needs of comprehensive molecular testing 
using only limited amount of tissue; therefore, staff members must make choices for 
analytical methods that lead to accurate, reliable, and cost-effective results (Dubbink et 
al., 2014). Because the validation of the test procedures and results are critical, 
participation and good performance in internal and external quality assurance schemes 
should be mandatory (Dubbink et al., 2014). For validation of comprehensive molecular 
assays, laboratories should consider test conditions, including the input of DNA, setup of 
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standard operating procedures, determination of coverage needed, and testing software 
applications prior to implementing new technology in the laboratory (Dubbink et al., 
2014). Revell and Chandramohan (2014) argued that validation should provide objective 
evidence that the total testing process is fit for the particular diagnostic purpose and 
meets the regulatory requirements for intended use. For laboratories residing in areas 
with no local consensus for validation of NGS tests, pathology laboratories should 
collaborate with specially trained clinical scientists in molecular pathology who are 
educated in design, analysis, and evaluation of molecular pathology tests and have 
knowledge on basic pathology (Nkengasong & Birx, 2014). Commercially available pre-
designed reference standards are tools to help disease detection accuracy and parallel 
testing (Dubbink et al., 2014). Diagnostic instrument manufacturers often design the 
reference materials and have the resources to connect with various laboratories. It can be 
a cost-effective approach for managers in the clinical laboratories to subscribe to the 
validation packages that are commercially available. 
Laboratory operations can affect patient results. Phillips, Njau, Li, and Kachur’s 
study (2015) on malaria showed that accuracy in diagnostic results directly impacted 
treatment effectiveness. Freedman (2015) argued that the staff’s ability to ensure that a 
test is appropriately ordered, properly conducted, reported in a timely manner, and 
correctly interpreted directly impacts the decision for patient treatment. Negative factors 
influencing test ordering by physicians, failure of guideline implementation, and 
inappropriate laboratory utilization could contribute to poor testing (Freedman, 2015), 
resulting in a delay in treatment and worsen patient condition (Hicks, 2015). 
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Harmonizing common testing practice can address the inconsistencies in test quality and 
improve patient outcomes across the whole patient pathway (Freedman, 2015). 
There has been an increase in funding for global health suggesting that efficient 
and reliable laboratory services and networks were necessary for high quality patient 
care, prevention, disease surveillance, and outbreak investigations (Gershy-Damet et al., 
2010). Recognizing the importance of laboratory quality globally, WHO has established a 
step-wise approach to help laboratories in developing countries. For example, sub-
Saharan Africa improves quality by acknowledging their current status, supporting them 
with a series of evaluations to demonstrate improvement, and recognizing their progress 
(Gershy-Damet et al., 2010), so patients across the globe can receive quality treatment. 
Dubbink et al. (2014) suggested laboratories residing in areas where accreditation and 
clinical testing standards are fully established collaborate to improve quality. The 
involvement of WHO in diagnostic laboratories located in developing countries not only 
motivates laboratories to drive quality initiatives, but also infers the impact of such 
quality in patient care. 
The diagnostic error can harm patients in many ways. For example, medical care 
could lead to financial harm to patients and families. In addition to financial harm, the 
amount of time spent on overuse could lead to a delay in effective treatment. Anxiety that 
medical tests trigger and the harm of social stigma could also worsen patients’ condition 
(Hicks, 2015). The ability to measure the incidence of diagnostic errors is critical to 
perform research on this subject and to initiate quality improvement projects aimed to 
reduce the risk of error as breakdowns in the diagnostic process can lead to staggering 
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toll of harm on patients (Hicks, 2015; Lippi et al., 2016). The laboratory tests’ turnaround 
time for emergency situations is often critical to patient care. Imoh et al. (2016) argued 
that by minimizing the quality of tests, there is potential to reduce turnaround time and 
improve patient survival in emergency care. This suggests that laboratory quality not only 
affects routine diagnostics but also emergency treatments.  
There are negative effects of false diagnostic tests beyond measurable patient 
care, and the improved quality of tests has the potential to reduce the undesirable 
outcomes. Incorrect diagnoses are associated with increased patient anxiety with no 
measurable health utility decrement. The United States Preventative Task Force was 
evaluating the harm caused by false-positive mammograms due to their common 
occurrence and their impact on the quality of life (Tosteson et al., 2014). The findings 
from measuring personal anxiety, health utility, and attitudes towards future screening of 
1226 participants showed that anxiety was significantly higher for women with false-
positive mammograms with similar health utility scores (Tosteson et al., 2014). In 
addition, data from the study by Tosteson et al. (2014) suggested that future screening 
intentions differed by groups where 25.7% of women with false-positive results intended 
to obtain future screening compared to 14.2% with negative results.  
Accurate and high-quality clinical support services are essential in the diagnostic 
process and treatment of patients. Plebani (2017) argued that in the past 50 years the need 
to control and improve quality in clinical laboratories had not only grown but was 
developed to expand along with technological developments. The introduction and 
monitoring of quality indicators, such as the analytical performance specifications, helped 
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reduce analytical errors drastically over time (Acuna et al., 2015; Plabani, 2017). To 
assure the most appropriate clinical outcomes, laboratory professionals should actively be 
involved as partners in the diagnostic team to improve upon clinical pathways and patient 
results. Although traditional laboratory quality efforts focus on the analytical phase, the 
quality of total testing process provides a more complete caliber and better insights for 
testing conditions.  
With increasing requests in target therapies and immunotherapies, there are 
growing demands in good pathology laboratory practice to ensure quality of care 
(Washetine et al., 2017). Although there are networks which support both diagnostic and 
clinical inpatient and outpatient care, there is a continuous flow of information to review 
regarding the quality assurance strategies (Hashjin, 2015; Pandey, Pabinger, Kriegner, & 
Weinhausel, 2016). Hashjin et al. (2015) performed a descriptive cross-sectional study in 
Iran among 84 hospitals to explore their quality approach. The results showed that the 
average reported application rate for the quality assurance strategies ranged from 57% to 
94% in the sampled population. Most frequent strategies were checking drug expiration 
dates (94%), pharmacopoeia availability (92%), equipment calibration (87%), and 
identifying staff responsibilities (86%). Hashjin et al. (2015) suggested that clinical 
chemistry and microbiology laboratories held the highest quality standards, and private-
for-profit hospitals valued quality more than governmental hospitals as there was room 
for improvement in general. Accurate and high-quality clinical support services are 
essential in the diagnostic process and treatment of patients and both private-for-profit 
and governmental hospitals should reassess their quality assurance strategies frequently. 
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Good laboratory practices not only enhance test quality and efficiency but also 
improve laboratories’ technical processes, competitive advantage, and market share 
(Manickam & Ankanagarl, 2015). Since quality has become a critical measure of 
performance and customer satisfaction, accreditation becomes an opportunity for 
laboratories to reassure their customers (Manickam & Ankanagarl, 2015). Marques, de 
Figueiredo, and de Gutierrez (2015) performed a study in Brazil and found poor health 
services contributed to poor patient care and unmet patient needs. The effectiveness in 
breast cancer screening in Brazil was low and customer satisfaction was below 
expectation, leading to more than 13,000 annual deaths in 2012 (Cecilio et al., 2015). The 
study in Brazil showed the importance of good laboratory practices and how it directly 
affected laboratories’ commercial operations and mortality.  
Laboratory medicine plays a pivotal role in the provision of healthcare; however, 
human errors have compromised clinical laboratory test accuracy (Li et al., 2016; 
Vecellio, Maley, Toouli, Georgiou, & Westbrook, 2015). To help reduce errors, Li et al. 
(2016) investigated possible causes and interventions by examining disqualified samples. 
Five error interventions were introduced: the integration of quality management system 
of samples in the pre-analytical phase into clinical information system, the application of 
standardized procedure on patients’ preparation, the standardization of sample collection 
process, the establishment of green channel for sample delivery, and the implementation 
of double-signing confirmatory system (Li et al., 2016). The findings showed that after 1-
year’s intervention, the incidence of pre-analytical errors decreased from 1.36% to 0.94% 
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(Li et al., 2016). This indicates that intervention measures can be effective, and human 
errors impact not only laboratory quality but also patient care. 
Accreditation and Regulations 
 The scrutiny on laboratory quality has increased over the years, and the 
compliance demands from clinical regulatory agencies have impacted the diagnostic 
laboratory industry. The FDA advanced two guidance drafts in 2014 for laboratory-
developed tests to set a regulatory framework for next-generation sequencing (Evans, 
Burke, & Jarvik, 2015). This initiative has kindled debates not only about the legal 
authority of the FDA for genomic testing but also the potential impact this regulation had 
on discovery and innovation. Typically, after the next-generation sequencing and other 
genomic tests identified a genetic variant, clinical validity would speak to its effect on 
health (Evans et al., 2015). There are significant challenges for clinical validity in 
laboratory-developed tests because the FDA only recognizes 76,606 unique variants with 
clinical interpretations, leaving millions of variants for which the FDA would require 
premarket studies to demonstrate clinical validity (Evans et al., 2015). The costs and 
delays to comply with premarket studies could deter many laboratories from providing 
anything beyond variant calls, driving laboratories in the United States out of the global 
business of genomic interpretation and diminishing the safety of American consumers. 
Due to the recognized importance in laboratory quality, there has been an increase 
in development funding for global health, suggesting that efficient and reliable laboratory 
services and networks are necessary for high-quality patient care, prevention, disease 
surveillance, and outbreak investigations (Gershy-Damet et al., 2010). Breakthrough of 
28 
 
the health status and disease detection required new strategies to control the processes 
(Acuna et al., 2015). WHO has established a step-wise approach to help laboratories in 
developing countries to improve quality by acknowledging their current stand, supporting 
them with a series of evaluations to demonstrate improvement, and recognizing their 
progress (Gershy-Damet et al., 2010). The lack of accreditation suggested that fulfilling 
the requirements of international and regional laboratory accreditation schemes was not 
commonly perceived as immediately feasible due to the current state of the laboratories. 
Factors that affect accreditation feasibility include the lack of trained laboratory experts, 
weak quality management systems, and the high cost associated with participation in 
international accreditation schemes (Gershy-Damet et al., 2010). The accessibility, 
affordability, scalability, and sustainability of quality programs in laboratories located in 
developing countries are the determining factors for enrollment (Gershy-Damet et al., 
2010). Affordable validation services performed by trusted instrument manufacturing 
organizations can be a solution for these laboratories.  
 The increasing scrutiny for laboratory quality is a global phenomenon. For 
developed countries, such as the United States, the regulatory agencies continue to 
improve their efforts in assisting laboratories to strive for better quality. Both Clinical 
Laboratory Improvement Amendments (CLIA) and College of American Pathologists 
(CAP) Laboratory Accreditation Program require clinical laboratories to verify 
performance characteristics, especially when introducing an unmodified approved test 
system, such as a medical diagnostic instrument. To comply with these requirements, 
periodic calibration and calibration verification should be performed (Killeen et al., 
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2014). Complying with clinical requirements helps make good medical decisions, and 
there is value in having periodic calibration and verification performed on diagnostic 
instruments. 
 For developing counties, such as most African countries, it is challenging to 
achieve laboratory quality standards set up by developed countries (Mbah et al., 2014; 
Nkengasong & Birx, 2014). Nigeria has adopted WHO’s improvement process towards 
accreditation in 2010, and the quality effort implemented resulted in measurable and 
positive impact on the laboratories in Nigeria (Mbah et al., 2014). To compete with 
global laboratories, managers in health laboratories in Nigeria continue to implement 
further improvements toward formal international accreditations (Mbah et al., 2014). The 
increased scrutiny in laboratory quality is observed not only in developed countries but 
also in developing countries and there is a demand for services designed to streamline the 
quality initiatives.  
 The current status of laboratory quality requirements may not be sufficient to 
ensure good quality, leading to potential compromises on patient care. Plebani, 
Sciacovelli, Aita, Padoan, and Chiozza (2014) argued that current laboratory 
accreditation recognizes the need to evaluate, monitor, and improve all the procedures 
and processes in the initial phase of the testing cycle but grouped pre-analytical errors 
into identification and sample problems. Lippi et al. (2016) argued that most of the 
approaches to improve diagnostic error rate have limitations. To provide valuable 
laboratory services, accreditation agencies should establish quality indicators, which 
allow the identification of errors and nonconformities, that can occur in all steps of the 
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pre-analytical phase (Plebani et al., 2014). Continuous updates and sustainable quality 
initiatives can minimize preventable patient harm. 
 The need for assurance in quality, cost reduction, and government regulation 
compliance has brought increased focus on validation in clinical diagnostic and 
pharmaceutical industry (Vijayasree et al., 2017). Three types of process validation 
according to the requirements stipulated by the United States Food and Drug 
Administration (FDA): prospective process validation, concurrent process validation, and 
retrospective process validation (Vijayasree et al., 2017). These process validations differ 
in the stage where documented evidence was established. Regarding the phases of 
process validation, phase 1 covers the pre-validation phase or the qualification phase, 
phase 2 covers the process validation phase, and phase 3 covers the validation 
maintenance phase (Vijayasree et al., 2017). There are four elements of validation: design 
qualification, installation qualification, operational qualification, and performance 
qualification. For each element, it is important that good manufacturing practices are 
observed to ensure reliability and efficiency (Vijayasree et al., 2017). Quality must be 
consistent at every step of the process, and performing a quality check only at the end of 
each product cycle is not sufficient to meet the stringent quality requirements stipulated 
by the United States FDA (Vijayasree et al., 2017). 
 Official regulatory requirements for laboratories are getting more stringent. As a 
result, good laboratory practice, good automated laboratory practice, and good 
manufacturing practice carry increased values; however, with the required stringent 
validation of analytical equipment and methods, the analysis costs increase significantly 
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(McMillan, 2016). Diagnostic instrument manufacturing organizations design and 
develop clinical diagnostic systems and are often equipped with resources to assist their 
customers in complying regulatory requirements. McMillan (2016) recommends that 
clinical laboratories use instrument hardware validated by manufacturers to gain 
efficiency in method development. 
Next-generation sequencing (NGS) and its applications have been growing in 
clinical industry and public health laboratories. The complexities of these next-generation 
sequencing assays called for a new set of standards to ensure testing quality as old 
established standards might not be applicable (Gargis, Kalman, & Lubin, 2016; Lyon et 
al., 2015). Targeted therapy is the current standard of practice for patients with 
hematologic malignancies (Kanagal-Shamanna et al., 2016). This type of therapy 
includes NGS-based analysis performed in clinical laboratories. The technology is fairly 
new and complex, leading to substantially different validation and test implementation 
between laboratories. There are three stages in the testing process: test development, test 
validation, and quality management (Kanagal-Shamanna et al., 2016). The test 
development phase includes sample preparation, target enrichment, sequencing, and 
analysis (Quail et al., 2012). General assay conditions, coverage, sample pooling, and 
analysis setting are all factors impacting the entire workflow in this phase (Kanagal-
Shamanna et al., 2016). For the test validation phase, laboratory staff should validate the 
entire test using established conditions, including known sensitivity, specificity, 
robustness, and reproducibility (Kanagal-Shamanna et al., 2016). In the quality 
management phase, laboratories should implement quality control in every sequencing 
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run and periodically perform staff proficiency tests (Kanagal-Shamanna et al., 2016). 
NGS applications have challenged validation, quality control, and data interpretation 
beyond what clinical laboratories previously encountered (Lyon et al., 2015), and clinical 
regulatory agencies are revising quality requirements rapidly to ensure these new 
applications are properly conducted.  
Given the rapid growth in the numbers of laboratory-developed tests, the FDA has 
become concerned that the absence of its oversight could compromise patient safety 
(Evans et al., 2015; Sidawy, 2015). As a result, the FDA outlines the laboratory 
requirements for reporting laboratory-developed tests and adverse events related to 
testing. The recent published FDA oversight ensured both analytical validity and clinical 
validity through its premarket review or approval process before a test was offered for 
clinical use (Caliendo & Hanson, 2016; Sidawy, 2015). When a laboratory made a 
significant change to the test, the test would be considered a new test and a notification 
should be provided before offering the modified laboratory-developed test. This FDA 
oversight for laboratory-developed tests has the potential to strike a balance that ensures 
patient safety without limiting beneficial and innovative test offerings. The oversight 
development shows that there is increasing quality scrutiny even for newly developed 
technology, such as the laboratory-developed tests. 
The laboratory-developed tests can be approved for clinical use under CLIA in the 
United States (Ferreira-Gonzalez et al., 2014). The FDA considers these laboratory-
developed tests to be medical devices under their regulatory jurisdiction; therefore, these 
tests are subject to regulatory scrutiny. Since CLIA allows clinical laboratories to modify 
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FDA-approved tests to develop their own tests as long as the laboratories follow the 
requirements to validate the performance characteristics of the laboratory-developed 
tests, the development of such tests has flourished, particularly when a medically-needed 
diagnostic is not available in an FDA-approved version (Genzen, Mohlman, Lynch, 
Squires, & Weiss, 2017). Contrary to the FDA’s regulatory jurisdiction, most clinical 
laboratories do not agree that laboratory-developed tests are a medical device, but a 
medical service (Ferreira-Gonzalez et al., 2014). As a result, most laboratory managers 
focused their validation process on analytic validity through accuracy and reliability as 
recommended by CLIA guidelines instead of FDA’s guidelines for good manufacturer 
practice. Ferreira-Gonzalez et al. (2014) reasoned that there is a need for an enhanced 
regulatory framework for these laboratory-developed tests because they pose risks to 
patient care and well-being. A good enhanced framework should come with the best 
features of CLIA’s regulatory framework for clinical laboratories with attention to the 
FDA’s approach for certain diagnostic medical devices. In addition, there is a need for a 
standardized validation process and such a standard should be developed and maintained 
with the assistance of an objective third-party body of experts to ensure independent 
review.  
The accreditation and regulation demands increased as the clinical biochemistry 
professional worked continuously to provide reliable results and optimize operational 
logistics (Acuna et al., 2015). Through obtaining laboratory accreditation, the laboratories 
ensure quality compliance while minimizing instances of error (Acuna et al., 2015; 
Manickam & Ankanagarl, 2015). There are new challenges in obtaining accreditation as 
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technological developments, the modular installation of automated equipment, and 
robotics require adaptations and new tools for designing and implementation of internal 
and external quality control as well as quality assurance. Additionally, breakthrough of 
health status and disease detection required new strategies to control the processes. The 
clinical accreditation should be considered mandatory in clinical laboratories because 
data have shown accreditation increased compliance in analytical quality management 
system (Acuna et al., 2015). For many countries, the voluntary clinical laboratory 
accreditation drives the costs of obtaining accreditation (Acuna et al., 2015). To drive a 
culture of total and continuous clinical quality assurance, a network of partnerships 
should be in place to gather resources and achieve affordable quality initiatives (Evans et 
al., 2015). 
The rapid adoption of NGS in clinical testing called for the development of new 
laboratory standards to regulate this technology. Aziz et al. (2015) suggested that a 
checklist for clinical NGS testing that set standards for the analytic wet bench process 
and for bioinformatics analyses could help set quality standards. The newly-added quality 
requirements by CLIA committee are used to address documentation, validation, quality 
assurance, confirmatory testing, exception logs, monitoring of upgrades, variant 
interpretation and reporting, incidental findings, data storage, version traceability, and 
data transfer confidentiality (Aziz et al., 2015). These new additions will standardize 
laboratory quality and should be adopted quickly by diagnostic laboratories to prevent 
gaps in patient care. 
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The development of new cancer treatments has shifted the focus of tumor 
evaluation in pathology towards molecular analysis (Cummings et al., 2016). Diagnostic 
molecular pathology, which determines the molecular aberrations present in tumors for 
diagnostic, prognostic, or predictive purposes, has faced with tissue and technological 
challenges due to the shifted focus (Dubbink et al., 2014). The laboratories have to meet 
the need of comprehensive molecular testing using only limited amounts of tissue, so 
choices must be made for analytical methods that lead to accurate, reliable, and cost-
effective results. The validation of the test procedures and results are critical. 
Participation and good performance in internal and external quality assurance schemes is 
mandatory (Dubbink et al., 2014).  
For validation of comprehensive molecular assays, Dubbink et al. (2014) 
suggested laboratories consider test conditions, including DNA-input, setup of standard 
operating procedures, determination of coverage needed, and testing software 
applications prior to implementing of new technology in the laboratory. For laboratories 
residing in areas with no local consensus for validation of NGS tests, collaboration 
amongst clinical scientists or using commercially-available pre-designed reference 
standards is critical for detection accuracy (Dubbink et al., 2014). Poor laboratory 
performance can lead to closure of the laboratory. It is in the best interest of laboratories 
to improve quality and testing reliability.  
Although obtaining accreditation seems to be a pathway to good laboratory 
quality and improved patient care, it is up to debate whether or not the quality standards 
are maintained after the laboratories receive accreditation. Dekaran and O’Farrell (2014) 
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performed a study to find out whether accredited hospitals and laboratories maintained 
quality and patient safety standards over the accreditation life cycle. Four phases of the 
accreditation life cycle were established: The initiation phase, the pre-survey phase, the 
post-accreditation phase, and the stagnation phase (Dekaran & O’Farrell, 2014). The 
initiation phase involved laying the foundation for achieving compliance with quality 
standards. The pre-survey phase occurred within 3 to 5 months of the accreditation 
survey, including a mock survey that identified existing quality gaps. The post-
accreditation phase referred to the period immediately after the accreditation survey. In 
the post-accreditation phase, most hospitals fell back towards pre-accreditation levels 
immediately because the staff no longer felt the pressure to perform optimally (Dekaran 
& O’Farrell, 2014). Dekaran and O’Farrell (2014) also reported a stagnation phase, 
following the post-accreditation slump, in which hospitals and laboratories operated 
with no new initiatives to drive further improvements. The findings from Dekaran and 
O’Farrell’s study (2014) suggested a reduction in compliance immediately after the 
accreditation survey. The lack of subsequent fading in quality performance was assuring 
to stakeholders as accredited hospitals and laboratories overall provided services of 
better quality than those that were not accredited. 
Good laboratory practices not only enhance test quality and efficiency but also 
improve laboratories’ technical processes, competitive advantage, and market share. 
Manickam and Ankanagarl (2015) argued that accreditation is the process that ensures 
good laboratory practices are implemented. To get accredited, laboratories should 
implement a successful laboratory management system. Manickam and Ankanagarl 
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(2015) showed that the size of the laboratory was irrelevant in its decision to implement a 
quality system; however, there were differences in the safety aspect: small laboratories 
carried lower safety index compared to larger facilities in the sample population. In 
addition, Manickam and Ankanagarl’s study (2015) showed the quality system 
management implementation process was not generally practiced effectively as there was 
a lack of quality measures for series of inter-related steps involving the use of 
instruments, reagents, staff, and related resources, which caused inefficiency in test 
results. There is a business opportunity for instrument manufacturing organizations to sell 
validation services that can address the quality gaps involving the use of instruments, 
reagents, and staff. 
Clinical audit is a process that provides opportunities for continual improvement. 
Since laboratory efficiency is directly connected to test result turnaround time, the 
clinical improvements in emergency tests are critical to patient care (Imoh, Mutale, 
Parker, Erasmus, & Zemlin, 2016). Imoh et al. (2016) administered a 6-month 
retrospective audit to determine the root cause of non-conformities and assess the 
effectiveness of changes made. Of the total of 1505 cerebrospinal fluid chemistry 
requests, the study found most delays occur during the transport of samples to the 
laboratory, especially during after regular work hours (Imoh et al., 2016). The findings 
offered an insight that drove changes to pre-analytical practices in the laboratory that 
would help improve test turnaround time and customer satisfaction. This study presented 
the advantages of clinical audits in addition to ensuring laboratory compliance such as 
patient health and customer satisfaction.  
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Tzankov and Tornillo (2016) argued that accreditation of clinical laboratories is a 
matter of course in the industrialized world. Early studies suggested that auditing 
laboratories apply standards established by trial-and-error, book knowledge, other 
evidence, or tradition. This led to a 55% accreditation rate and 10% fail rate while the 
other 35% required significant efforts to meet accreditation requirements (Tzankov & 
Tornillo, 2016). Although accreditation provided a hallmark of performance and 
competence, it could not substitute for professional competence (Tzankov & Tornillo, 
2016). Some laboratory errors still occurred in accredited laboratories, suggesting that 
accreditation could not prevent all mistakes. Furthermore, according to the ISO 
accreditation guidelines, all processes, procedures, and examinations related to pathologic 
diagnostics must be documented as standard operating procedures that are current and 
accessible to the laboratory staff, providing practical advantages (Tzankov & Tornillo, 
2016). Tzankov and Tornillo’s experience (2016) showed that accreditation provided 
practical advantage by standardization, helped eliminate waste, reduced unnecessary 
interfaces and intermediate steps, improved processes and procedures, and decreased the 
number of technical errors. The caveats for laboratory accreditation were that it should be 
meant to improve the end results for patients. Processes often had limited influence on 
results and introduced bureaucracy. Tzankov and Tornillo (2016) argued that although 
there are proven advantages of accreditation, the excessive multiplication of written 
documents demanded is unnecessary. Purchasing already standardized documented 
validation packages, such as the instrument installation qualification, operational 
qualification, and analytical validation, can reduce the burden of producing written 
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documents for clinical laboratories and allow laboratory members to focus on helping 
patients.  
Not everyone agrees that laboratory accreditation can improve clinical quality. 
Wilson, Smye, and Wallace (2016) argued that ISO accreditation arose from factory 
inspection during World War II, which can be obsolete. Wilson et al. (2016) reviewed 
data from 14 years of internal and external laboratory audits that checked compliance 
with ISO 17025 in a public health laboratory and found that most non-compliance came 
from clauses in the standard that would not affect patient results. Because fewer than 1% 
of non-compliances were likely to produce poor quality of laboratory service, Wilson et 
al. (2016) recommended that management obtain positive proof before using the 
standards to deliver the efficacy, effectiveness, and value required of modern healthcare 
interventions. Contrary to Wilson et al. (2016), Zehnbauer et al. (2017) argued that well-
developed formal evaluation including reference samples and standardization are 
necessary. It is in patients, providers, payers, manufacturers, regulatory agencies, and 
laboratories’ best interest to strive for not only consistent and accurate testing results but 
also transparent and comparable outcomes with quality measures implemented across test 
platforms. 
Obtaining accreditation and abiding by regulatory requirements is not just a 
quality initiative for clinical laboratories. Physicians are the primary customers of the 
clinical laboratory (McCall et al., 2016). Both the College of American Pathologists 
(CAPs) Laboratory Accreditation Program and the Joint Commission recognize the 
importance of customer satisfaction as part of their respective accreditation programs 
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(McCall et al., 2016). In addition to monitoring laboratories’ communication processes, 
the efficiency in information transfer, completeness of test requisition, timeliness of 
reporting results, and report accuracy are all included in the customer satisfaction 
evaluation (McCall et al., 2016). McCall et al. (2016) concluded that high physician 
satisfaction and loyalty with clinical laboratory services helped laboratories remain 
accredited. Clinical laboratories looking to retain customers should consider laboratory 
accreditation as not only a quality indicator but also part of customer satisfaction 
assessment. 
Instrument Manufacturing Organizations’ Role 
Diagnostic instrument manufacturing organizations are not just providers for the 
equipment but also facilitators in research, healthcare, and quality management. Fleming 
performed a study in 2015 to show the relationship between medical device funding and 
innovation. In the early stage of the device development, device safety and effectiveness 
play an important role (Fleming, 2015). In the midstage, stability, regulatory standards, 
and clinical trial plans become crucial to funding decisions (Fleming, 2015). Throughout 
the innovation process, regulatory and reimbursement policies have a profound impact on 
the amount of capital in laboratories (Fleming, 2015). Using data from quarterly 
investment statistics submitted by the venture capital industry since 1995, Fleming (2015) 
compared the four quarters of 2009 to 2014 and found the amount invested in life 
sciences and biotechnology companies shrank and that FDA approvals had the highest 
impact on the investors’ decision making. One of the key factors that Fleming (2015) 
argued could affect funding was regulatory policies. Since compliance service packages 
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are designed to help clinical laboratories pass regulatory inspections and establish good 
laboratory practices, there is value in using instrument manufacturing organizations’ 
validation products. These manufacturing organizations’ representatives can take care of 
the compliance documentation while scientists focus on innovation. 
In addition to facilitating innovations, instrument manufacturing organizations 
can help laboratories streamline the quality processes. Accurate and high-quality clinical 
support services are essential in the diagnostic process and treatment of patients (Hashjin 
et al., 2015). Quality assurance strategies in clinical inpatient and outpatient care involve 
checking reagent expiration dates, pharmacopoeia availability, equipment calibration, and 
identifying staff responsibilities (Hashjin et al., 2015). Lanman et al. (2015) suggested 
performing a thorough analytical validation on the entire NGS workflow to prevent false 
positive results. Lyon et al. (2015) stated NGS applications are unique which add 
complexity in validation quality control and data interpretation. The major challenge in 
validating an assay involves optimizing three components at once: the sequencing 
platform, the specific test of genes, and the bioinformatics pipeline (Lyon et al., 2015). 
Each time one of the three components changes, the entire workflow must be re-
validated. Since these validations take days to weeks to complete, the costs associated 
with re-validation are not trivial (Lyon et al., 2015). Another commonly faced challenge 
is the ability to identify a gold standard set of samples and sequence data containing a 
broad heterogeneity of known sequence variants (Lyon et al., 2015). The instrument 
manufacturing organizations often manufacture the corresponding reagents, assays, and 
control samples. In addition to understanding the instrument specifications and functional 
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tests, representatives from the manufacturing organizations have access to workflow and 
instrument compatibility and test data. It is beneficial to clinical laboratories to 
collaborate with manufacturers on total workflow validations. 
Having instrument manufacturing organizations perform instrument validation 
can help standardize laboratory quality because the validation process will be identical. 
Miller, Tate, Barth, and Jones (2014) argued that harmonization of clinical laboratory test 
results will lead to results comparable irrespective of the processing procedure used and 
where or when the results were obtained. The uniform test results can help physicians 
reach diagnoses more efficiently; however, poor coordination of the effort among 
different professional organizations can lead to terminology confusion, ambiguous 
calibration traceability to a reference system, poor reference material, and unclear 
specificity of the measurement of the biomolecule of interest (Mill et al., 2014). The 
solution to clinical harmonization is to have organized global support (Nkengasong & 
Birx, 2014). Instrument manufacturing organizations are often equipped with a support 
system to deliver cost effective and clinically optimized laboratory services to achieve 
clinical harmonization. 
Having instrument manufacturing organizations perform diagnostic instrument 
validations does not always guarantee quality. Powell et al. (2013) concluded that third-
party audits and inspections, although independent and within legal framework, cannot 
prevent all the mishaps. Understanding the limitations of inspections and the scope of 
third-party services is a more practical quality verification method (Powell et al., 2013). 
Sciacovelli et al. (2017) stated that active participation in inter-laboratory comparison 
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allows information on the performance level because laboratories can partake in 
numerous initiatives that promote the reduction of errors and enhancement of patient 
safety and at the same time, share experiences and resources with other clinical 
laboratories. Since many of the laboratories use the same brand of diagnostic instruments, 
the instrument manufacturing organizations can be the intermediaries that connect 
laboratories. 
Acquisition of new equipment or implementation of any new diagnostic assay in 
clinical laboratories requires validation and verification (Revell & Chandramohan, 2014). 
It is critical that the laboratory collects subjective and objective specifications to map out 
the potential process change and define functional criteria. There are practical 
considerations involved in the selection and implementation of new equipment and assay 
so that the laboratories can maintain or improve the reliability, efficiency, and clinical 
utility of the testing systems. These considerations include: changing clinical needs of the 
community served by the laboratory, new guidelines or recommendations for diagnostic 
testing by regulatory agencies, emergence of new and promising technologies, a need for 
improved turnaround times for critical tests, and clinicians’ interest in providing tests that 
have improved diagnostic confidence (Revell & Chandramohan, 2014). Verification and 
validation provide important objective evidence that the system is fit for purpose and 
meeting particular requirements for intended use (Sandhya et al., 2015). In addition, 
monitoring and disseminating information about trends in proficiency testing 
performance could assist individual laboratories in assessing their quality and 
performance compared to other similar laboratories (Revell & Chandramohan, 2014). 
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Instrument manufacturing organization provided validation services are helpful in 
achieving objective evidence and compare trends. 
Official regulatory requirements for laboratories are getting more stringent. As a 
result, good laboratory practice, good automated laboratory practice, and good 
manufacturing practice carry increased values; however, with the required stringent 
validation of analytical equipment and methods the analysis costs increased significantly 
(McMillan, 2016). Clinical laboratories should use instrument hardware validated by 
manufacturers to gain efficiency in method development and to control costs.  
Instrument manufacturing organizations’ global presence and network can help 
bridge the gaps in laboratory accreditation programs between developing countries and 
developed countries. Smits, Supachutikul, and Mate (2014) argued that accreditation 
programs in the low- and middle-income countries follow the same basic structure and 
process as the developed countries; however, in low- and middle-income countries, the 
focus is primarily on improving overall care while supporting the under-performing 
facilities, different from developed countries where the accreditation efforts focus on 
identifying the best institutions that meet the stringent evaluations. Instrument 
manufacturing organizations’ global product placement can help gather information on 
new accreditation requirements as well as standardize laboratory protocols through 
common customer training and documentation process. 
Engineers in instrument manufacturing organizations set the instrument 
specifications’ intended use. Scientists in these organizations design the control samples 
to verify test results that are generated by the instruments. As a result, the manufacturing 
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organizations own most technical knowledge for the equipment they design and 
manufacture (Hill, 2011). Instrument validation is a prerequisite for commissioning 
equipment, and it ensures that the intended process meets the desired outcomes 
(Agnihotri et al., 2013). Laboratories rely on information supplied by the manufacturers 
when introducing new measurements into the laboratory (Hill, 2011). Revell and 
Chandramohan (2014) found it is critical that the laboratory collects subjective and 
objective specifications to map out the potential process change and define functional 
criteria when introducing new equipment. Since verification of clinical instruments is 
mandatory for clinical diagnostic use (Vis & Huisman, 2016), using validation services 
provided by the instrument manufacturing organizations can be an efficient method to 
verify prevision, accuracy comparability, carryover, background, and linearity of 
diagnostic output according to the original designed range of acceptance criteria. 
There is a trend leading towards personalized precision medicine. As a result, the 
broad and sustainable availability of accurate and precise diagnostic tests have become 
crucial factors for the success of the innovative targeted therapies (Enzmann, Meyer, & 
Broich, 2016). The current regulatory standards require in vitro diagnostics be certified 
based on their manufacturers’ assessment (Enzmaan et al., 2016) and mandate 
laboratories to follow equipment manufacturing organizations’ directions to operate the 
diagnostic instruments (Endrullat, Glokler, Franke, & Frohme, 2016) so that there is data 
traceability and reproducibility. Sandhya, Bonthagarala, Sai, and Sivaiah (2015) argued 
that installation qualification, operational qualification, and performance qualification are 
the most valid process validation methods to assure quality. Instrument manufacturing 
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organizations’ validation packages include installation qualification, operational 
qualification, and performance qualification. By purchasing these validation packages, 
members in clinical laboratories can assure quality without the concerns for defining the 
process validation elements.  
Aside from having the most technical knowledge of the instruments, 
manufacturing organizations often have more resources to follow regulatory 
requirements. Lyon et al. (2015) found that the ability to identify a gold standard set of 
samples and sequence data is critical for NGS data quality and validation success. Miller 
et al. (2014) argued that an extensive global reference system is the solution to data 
interpretation confusion, which can cause laboratories citations from local regulatory 
agencies. In developing countries, the regulatory requirements for clinical laboratories 
can vary vastly from developed countries (Nkengasong & Birx, 2014), and it can be a 
challenge for individual laboratories to follow constantly-updated regulatory information. 
Smits et al. (2014) concluded that when a clinical organization expands its business, they 
often need assistance in keeping up with the quality to pass accreditations. Zehnbauer et 
al. (2017) stressed the importance of standardization in achieving consistent and accurate 
testing results across test platforms. Keeping up with evolving regulatory requirements 
can be a challenge for clinical laboratories. Instrument manufacturers’ dedicated 
regulatory and compliance teams have the resources to stay up-to-date with compliance 




 Dynamic capabilities are higher-level competences that allow organizations to 
integrate, build, and reconfigure internal and external resources to address and shape the 
rapidly changing business environments (Salvato & Vassolo, 2017). Barrales-Molina, 
Martinez-Lopez, and Gazquez-Abad (2014) argued that marketing resources and 
capabilities play an important role in determining the needs of customers and distribution 
channels. The organization’s dynamic capabilities can directly impact its marketing 
resources (Barrales-Molina et al., 2014). Kaleka and Morgan (2017) argued that due to 
the expansion of trade and rapid competitive responses, business managers need to 
develop and maintain asset alignment capabilities and collaborate with each other to 
combine resources to deliver value to customers. The organization’s ordinary capabilities 
allow it to perform efficiently; however, dynamic capabilities are what enable the 
enterprise to position itself to address market needs and the competitive opportunities of 
the future (Salvato & Vassolo, 2017). Due to the nature of dynamic capabilities, 
innovating organizations looking to pioneer a market or a new product category depend 
on them to succeed. The NGS market is relatively new in the clinical diagnostic industry 
(Cummings et al., 2016), and diagnostic instrument manufacturing organizations can 
utilize dynamic capabilities to drive sales in their instrument validation packages. 
 The purpose of an organization is to enable and facilitate coordination and 
collective effort by individuals; however, entrepreneurial and professional management 
ability often is not sufficient to manage the economic activity that exists in the 
organization (Kaleka & Morgan, 2017). Managers in the organization direct operations 
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and are often the agents of the principals. As a result, managers usually have considerable 
strategic discretion over the allocation of resources (Kaleka & Morgan, 2017). In a 
competitive market, entrepreneurs and managers need to orchestrate necessary responses 
to technological and market changes to maintain organizational continuation (Teece, 
2014). The dynamic capabilities framework invites further research into 
entrepreneurship, organizational learning, and the role of managers in enterprise 
performance (Teece, 2014). In addition, dynamic capabilities focused on economic 
flexibility, adaptability, integration, and disintegration (Kaleka & Morgan, 2017). Current 
business environments with changing technology require the understanding of complex 
business organizations and contemporary management practices in high-performing 
enterprises, and dynamic capabilities framework could serve as practical guidelines. 
There are relationships between laboratory staff and medical device 
representatives that can affect sales. The financial connections between the medical 
device industry and clinical staff can contribute to clinical reliance on industry product 
claims (O’Connor, Pollner, & Fugh-Berman, 2016). O’Connor et al. (2016) performed a 
study and showed medical device representatives who visited hospitals daily and were 
made available by phone for 7 days a week had better sales results. The relationship 
between the medical device representatives and the clinical staff impacted the costs and 
device selection dynamics (O’Connor et al., 2016). O’Connor et al. (2016) concluded that 
the two major factors influencing clinicians’ equipment choices were the costs and the 
quality of the services offered by the medical device representatives who sold them. 
Beatty et al. (2016) argued that companies can struggle to deliver excellent service if they 
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do not understand and plan for customer requests. Failing to comply with customer 
requests can impact customer satisfaction. Since representatives from the diagnostic 
instrument manufacturing organizations already have interactions with their customers 
during the instrument sales, they have already established relationship with the clinicians 
and understood their customers’ needs. Taking advantage of this existing relationship and 
providing the products and services to help increase customers’ laboratory efficiency can 
be beneficial to the sales of instrument validation packages. 
Dynamic capabilities have shaped the outcome of high-growth organizations. 
Barrales-Molina et al. (2014) posited that the organization’s dynamic capabilities in 
marketing could impact its strategic position to absorb market knowledge. Szalavetz 
(2015) argued that managers should not create a single solution or routine for their 
operations, but continually re-configure or revise the capabilities they had developed. In 
addition, when necessary, leadership should reconfigure the organization’s tangible and 
intangible assets to seize opportunities and maintain competitiveness (Szalavetz, 2015). 
Szalavetz’s study in 2015 showed that successful entrepreneurs in technology-oriented 
sectors could seize opportunities if they were able to combine technology development 
with business development. The recurrent growth-related reconfigurations of 
organizational structures and introduction of various organizational innovations are the 
result of systematically developed dynamic capabilities and non-abating organizational 
learning (Szalavetz, 2015). NGS is a rapid growing technology, and organizations that 
manufacture and support NGS share similar backgrounds as the participants in 
Szalavetz’s study (2015). Taking advantage of dynamic capabilities in marketing 
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development will help NGS manufacturing organizations gain opportunities and increase 
competiveness. 
Although new products and innovation are often vital sources of revenue and 
competitive strength, the risk of these failing is often high, especially in organizations in 
a competitive environment (Zhang & Wu, 2017). Research focused on traditional success 
factors for new products: customer input, market orientation, technological synergy, and 
company resources. Nonetheless, there is an increasing impact from organization’s 
external business networks. Some scholars argued that a strong internal resource base 
was key to the effective absorption of external knowledge while others argued that such 
an internal resource base could hinder external knowledge absorption due to internal 
resistance (Zhang & Wu, 2017). The resource-based view suggests that an organization’s 
capability to use resources translates the benefits of individual resources into superior 
performance. Still, its lack of distinctive focus on resource interaction effects fails to 
explain the process through which resource-interplay might help an organization achieve 
new product success (Zhang & Wu, 2017). The dynamic capabilities perspective suggests 
that resources by themselves are not sufficient to create value for an organization, 
particularly in changing environments. Resource-interplay provides a necessary but 
insufficient condition for new product success and dynamic capabilities transform the 
benefits of resource-interplay into successful new product development (Zhang & Wu, 
2017). When NGS instrument manufacturing organizations develop instrument validation 
packages, it is to their advantage to incorporate customer feedback and external resources 
so their offerings address practical customer needs. 
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Medical device and laboratory product sales performance can vary. Robinson 
(2008) argued that the performance of the medical device fell short of its potential 
because the way the products were assessed, purchased, and used was not optimized due 
to a misalignment of information and incentives. Services selected and prices paid sent 
important signals to diagnostic instrument manufacturing organization signals as to where 
to extend capabilities, to invest, and to innovate. In addition, understanding the 
consumers’ purchasing choices allows manufacturing organizations to design products 
and services that could meet customers’ expectations and needs (Robinson, 2008; Quail 
et al., 2012). Quail et al. (2012) compared NGS platforms across three different 
manufacturing organizations and found that customers made purchasing choices based on 
available resources, existing infrastructure, personal experience, finances, and the types 
of applications. When developing NGS validation packages, organizations can gain value 
in their products by taking account for the voice of the customers.  
There are other ways for diagnostic instrument manufacturing organizations to 
gain value in their products and services aside from taking advantage of dynamic 
capabilities. Trajkovic and Milosevic (2016) stated that economic, technical, and policy 
standardization all play a role in helping business organizations achieve goals. As the 
world and businesses become interconnected, organizations should not ignore the power 
of collaboration and standardization (Trajkovic & Milosevic, 2016). The relationship 
between the customers, clinical laboratories, and the instrument manufacturing 
organizations can impact the value in products and services offered. Dang et al. (2014) 
showed customer perception is related to satisfaction in the clinical settings. O’Connor et 
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al. (2016) performed a study in medical centers and indicated that device representatives’ 
relationship with the medical staff influenced the equipment choices. Beatty et al. (2016) 
showed when customers asked frontline employees to perform activities that went 
beyond their expectations, there was an increase in customer satisfaction which could 
lead to organizational benefits. Aside from customer relationships, Powell et al. (2013) 
argued that by developing a strong culture in quality, including risk-based verification 
steps throughout the safety system, manufacturing organizations can help find a more 
cost-effective way to provide an objective value. Robin (2008) argued that price 
transparency, performance data, and quality of the products contribute to the value of 
medical devices. To market products and services successfully, diagnostic instrument 
manufacturing organizations should use dynamic capabilities to rally internal and 
external resources to design and manufacture what customers need, build positive 
relationships, construct a culture of quality, and share performance data to provide 
product transparency. 
Resource-Based Theory  
Although dynamic capabilities allow organizations to integrate, build, and 
reconfigure internal and external resources in the rapidly changing business environment 
(Salvato & Vassolo, 2017), many scholars prefer using resource-based theory to explain 
how organizations can thrive under competition (Kozlenkova, Samaha, & Palmatier, 
2014; Nalcaci & Yagci, 2014). Resource-based theory is a framework for explaining and 
predicting competitive advantages and performance outcomes (Kozlenkova et al., 2014). 
Resource-based theory addresses the value of resources as resources lead the 
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development of organizational skills and capabilities (Arend & Bromiley, 2009; Nalcaci 
& Yagci, 2014). The basis of organizational competitiveness consists of the accumulation 
of valuable, rare, inimitable, and non-substitutable resources (Lin & Wu, 2014). 
Kozlenkova et al. (2014) argued that the use of resource-based theory in marketing 
research has increased by more than 500% in the past decade, suggesting its importance.  
Researchers argue that factors internal to the organization and the organization’s 
resources and capabilities determine its profits and competitive advantage (Kozlenkova et 
al., 2014). Nalcaci and Yagci (2014) performed a study on manufacturing companies 
regarding their marketing capabilities and found that organizations’ informational and 
financial resources, along with customer relation’s capabilities, have a positive 
relationship with marketing success. Kozlenkiva et al. (2014) posited that a resource-
based logic can often serve to investigate two goals of market expansion: expanding into 
new markets to gain advantages from existing resources and expanding into new markets 
to develop new resources that can generate advantages in both new and existing markets.  
Although resource-based theory seems to compete with dynamic capabilities 
theory in marketing studies, Lin and Wu (2014) argued that there is a role of dynamic 
capabilities under the resource-based view framework. While resource-based view 
emphasizes the value of resources, the dynamic capabilities view addresses the need to 
incorporate changes in valuable resources (Arend & Bromiley, 2009). The changing 
industry environment can alter competitive foundations and dynamic capabilities of the 
organization, determining its ability to reconfigure resources to deal with volatile 
environment (Lin & Wu, 2014). The lack of distinctive focus on resource interaction 
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effects in resource-based view cannot address the complex resource-interplay (Zhang & 
Wu, 2017). The organization’s internal resources can directly impact its integration, 
learning, and reconfiguration capabilities, which are types of dynamic capabilities (Lin & 
Wu, 2014). Combining resource-based view and dynamic capabilities view not only can 
help organizations accumulate resources but also mediate resources in the competitive 
environment (Lin & Wu, 2014).  
The dynamic capabilities perspective suggests that resources by themselves are 
not sufficient to create value for organizations in changing and competitive environments 
(Zhang & Wu, 2017). Jeng and Pak (2016) argued that an organization’s ability to deploy 
resources through its organizational capabilities is more important than the amount of 
resources itself. In small organizations, dynamic capabilities are crucial to withstand 
competition while in large enterprises, dynamic capabilities help build long-term strategic 
advantages (Jeng & Pak, 2016). Marketing dynamic capability refers to the 
organization’s ability to increase the value of its products and services while 
differentiating them from those of its competitors (Jeng & Pak, 2016). Utilizing dynamic 
capabilities to build links between the organization and its customers can enable the 
organization to better compete by predicting changes in customer preferences (Jeng & 
Pak, 2016). Therefore, for new product and marketing development, the organization’s 
dynamic capabilities can help combine both internal and external resources to increase 
competitive advantage (Jeng & Pak, 2016). Since NGS technology is relatively new 
(Kanagal-Shamanna et al., 2016) and the clinical regulatory environment is constantly 
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changing (Demortain, 2017), dynamic capabilities view can address marketing success in 
NGS instrument validation packages better than resource-based view. 
Transition  
Section 1 includes the problem statement, purpose statement, nature of the study, 
and the research question. These sections help define and guide the stages, reporting, and 
analysis of the study. The inconsistent quality of oncology diagnostic laboratories 
continues to produce false positive and false negative results, causing patient harm 
(Hicks, 2015). Diagnostic instrument manufacturing organizations’ offering of validation 
packages can help laboratory streamline processes, increase efficiency, obtain 
accreditation, and improve test accuracy. Exploring how successful business 
development managers in a diagnostic instrument manufacturing organization design, 
develop, and market the validation packages will assist other managers in the same 
industry with marketing strategies that lead to increased sales, creating a laboratory 
culture with the standardized quality approach.  
Dynamic capabilities determine an organizations’ ability to build, integrate, and 
realign internal and external resources to address changing business environments 
(Teece, 2010). The purpose of this qualitative single case study was to explore what role 
dynamic capabilities play to help successful business managers market instrument 
validation packages that are appealing to their targeted customers, decision-makers in the 
oncology clinical laboratories. The review of professional and academic literature 
contained key and recent findings in the clinical, regulatory, business, and marketing 
field that were relevant to this study.  
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Section 1 includes (a) interview questions, (b) conceptual framework, (c) 
operational definitions, and (d) assumptions, limitations, and delimitations of the study. 
In addition, Section 1 includes the significance of the study and review of the 
professional and academic literature. Section 2 will cover the following subjects: (a) 
purpose statement, (b) role of the researcher, (c) study participants, (d) research 
methodology and design, (e) population and sampling, (f) ethical research, (g) data 
collection, (h) data organization, (i) data analysis, and (j) reliability and validity. Section 
3 will include (a) presentation of the findings, (b) implications for social change, (c) 




Section 2: The Project 
The purpose of this qualitative exploratory single case study was to explore the 
marketing strategies business development managers use for integrating dynamic 
capabilities into clinical instrument validation packages. In Section 2, I will deliver 
information on the project, including the role of the researcher, participants, research 
method, and research design. I will also cover details regarding my population and 
sampling technique, data collection analysis procedures, ethical research, and the 
reliability and validity of the study. 
Purpose Statement 
The purpose of this qualitative single case study was to explore what marketing 
strategies successful managers in a diagnostic instrument manufacturing organization 
used to promote sales of validation packages for increasing the accuracy of oncology 
laboratory test results. The targeted population consisted of managers in an NGS 
instrument manufacturing organization located in the western United States who had 
successfully marketed validation packages. The population was appropriate for this study 
because research suggested compliance services lead to resource-efficient diagnoses 
(Gagan & Van Allen, 2015) and most in vitro diagnostics had been certified based on the 
manufacturers’ assessment (Enzmann, Meyer, & Broich, 2016). The reduction of testing 
errors and decrease in inappropriate treatment would enhance the quality of healthcare for 
patients (Long-Mira, Washetine, & Hofman, 2016). The implication for positive social 
change includes positive improvement for patient care. 
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Role of the Researcher 
Researchers have the role of an investigator in the data collection process and 
should abide by the guidelines of the Institutional Review Board (IRB) for the study (Bell 
& Waters, 2014). The relationship between researchers and study participants has been a 
recurrent concern in the methodological literature because the researcher’s experiences, 
reasoning, and overall impact throughout the research process can affect study 
participants’ behavior (Raheim et al., 2016). Many qualitative studies involve humans as 
the main research instrument; therefore, it is important for the researchers to keep an 
open mind throughout the study for unbiased analysis (Peredaryenko & Krauss, 2013). 
However, researchers’ experience in the study topic can also improve the amount of 
details gathered in the interview (Dempsey, Dowling, Larkin, & Murphy, 2016). As a 
product manager in a clinical instrument manufacturing organization, I was familiar with 
various interview techniques as well as the various instrument validation packages that 
are available in the clinical diagnostic market. The concepts concerning the interview 
process recommended by Brinkmann (2016) helped me design and guide the interviews 
with unbiased respect and my professional experience in the clinical diagnostic field 
helped me construct contents related to my research question. My role was to interview 
four participants from an NGS instrument manufacturing organization, collect and 
analyze data, and manage the interview process while protecting the privacy of the 
participants. 
The Belmont Report provides ethical principles and guidelines for the protection 
of human subjects of research, and is critical in protecting research participants and 
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maintaining the ethics in research (Friesen, Kearns, Redman, & Caplan, 2017). To avoid 
exposing participants to any potential harm and perform ethical research, it is the 
researcher’s responsibility to conduct the study according to the Belmont Report protocol 
(Marshall & Rossman, 2016). The three major components of the Belmont Report—
respect, beneficence, and justice (Miracle, 2016)—enhanced the research experience for 
both the researcher and the participants. 
Biases often skew the interpretation of the results and affect the full dissemination 
of qualitative studies (Toews et al., 2017). Professional conversation during the research 
interview to enhance research experience for both the researcher and study participants 
(Brinkmann, 2014). Additionally, professionalism in research can increase participants’ 
engagement, reduce interview stress, and minimize bias (Antes et al., 2016). To minimize 
personal prejudice in my study, I ensured that my relationship with the study participants 
remained neutral and professional. To warrant the integrity and credibility of research 
findings, I collected data with honesty and interpret the data fairly as suggested by Noble 
and Smith (2015).  
One of the most common researcher biases during research is confirmation bias 
(Bashir, Sirlin, & Reeder, 2014). Confirmation bias occurs when the researcher poses 
subjectivity in the research process, resulting in subjective filtering of data (Paap, 2014). 
People with a cooperative mindset show more flexible thinking and less confirmation 
bias (Schwind & Buder, 2012). I performed a series of reassessments of my interpretation 
of participants and challenged my preexisting assumptions.  
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To reduce interview bias, Hilgert, Kroh, and Richter (2016) suggested using 
standardized interview process. Interview structure and standardization can reduce bias 
and variation (Levashina, Hartwell, Morgeson, & Campion, 2014). Standardized 
interviews reduce subjective outcomes and detection bias (Tully & Baumeister, 2015). I 
interviewed the participants based on their current job responsibility related to the study 
topic, and I used an interview protocol (Appendix A) to standardize the interview 
process.  
Participants 
To gain access to pertinent data to study business problems effectively, 
researchers need to recruit participants with relevant knowledge and experience 
(Palmatier, 2017). Chandler and Paolacci (2017) recommend researchers define 
eligibility criteria with details to ensure that the participants’ characteristics align with the 
research topic. The participants in this single case study included senior managers 
currently employed by an NGS instrument manufacturer who had been successfully 
selling validation services to their clinical customers. The specific eligibility included a 
minimum of four employees and current achievement of revenue growth in compliance 
services offered to provide responses related to the overarching research question.  
Participants’ knowledge and experience affect the data for qualitative studies 
(Knapik, 2006). Chandler and Paolacci (2017) argued that blind recruitment of study 
participants may attract imposters who misrepresent theoretical relevancy. Dean et al. 
(2016) recommended recruiting study participants with relevant knowledge and 
experiences through internal resources. Recommendations from the regional service 
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manager of an NGS instrument manufacturer in the western United States —from two 
field applications scientists who were in customer-facing roles supporting clinical 
diagnostic sequencing laboratories and four field service engineers who were in 
customer-facing roles and were responsible for executing the validation packages for an 
NGS instrument manufacturer—helped establish an initial list of 10 participants. From 
the list of recommendations, I invited participants until a minimum of four qualified 
participants had given their informed consent. To ensure I have access to participants, I 
asked a director-level manager of the organization to sign a letter of cooperation based on 
previous researchers who used letters of cooperation (Bayu et al., 2016; Hadush et al., 
2017; Tenaw, Yohannes, & Amano, 2017) . 
Recruitment of participants into the research study is an essential part of the 
research process (Newington & Metcalfe, 2014). Failure in recruitment can not only fail 
the study but also lose the study’s potential impact on the field of science (Joseph, Keller, 
& Ainsworth, 2017). Establishing a working relationship can help engage participants 
and improve data collection quality (Jack, DiCenso, & Lohfeld, 2016). Study participants 
receive better experience with a good working relationship (Kivlighan et al., 2016). To 
foster a working relationship with the participants, I wrote an e-mail to introduce myself 
and provided a summary of the goal of the study. All invited participants received 
descriptive information on the research design and the background of the study. I 
discussed the purpose of the study, details of intended questions, and an overview of the 
type of data I intended to collect during the qualifying conversation with the potential 
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research participants. Many of the potential participants were colleagues with whom I 
had collaborated in the past on various boards of project.  
Participants’ characteristics can affect data analysis and interpretation in 
qualitative studies (Bradley, Curry, & Devers, 2007). The characteristics of the 
participants might also influence the interactions between the researcher and the data 
quality (Holloway & Galvin, 2016). Recruiting participants with common experiences or 
characteristics related to the overarching research question is an efficient approach for the 
researchers as it helps the researcher reduce unnecessary variables (Lavallee et al., 2017). 
The research question for this study was “What marketing strategies did managers in 
oncology instrument manufacturing organizations use in validation packages to increase 
laboratory testing accuracy in  the western United States?” I recruited managers currently 
employed by an NGS instrument manufacturing organization who had been selling 
validation packages to their clinical customers successfully. These managers’ common 
characteristics in the achievement of revenue growth and employment in the same 
oncology instrument manufacturing organization aligned with the overarching research 
question for this study. 
Research Method and Design  
I performed a qualitative exploratory single case study with a purposeful sampling 
of participants. A qualitative case study offers insights into why people engage in 
particular actions (Leung, 2015; Rosenthal, 2016). A case study is most suitable for 
exploring an issue through analysis and in-depth description of a bounded system 
(Creswell & Poth, 2017). Therefore, performing a single case study allowed me to direct 
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the focus of this research on the success factors in a real-life context. I used a purposeful 
sample and methodological triangulation, including participant interviews, member 
checking, and observations at the Interservice/Industry Training, Simulation, and 
Education Conference (I/ITSEC) with virtual simulation and training. 
Research Method 
Scholars use one of three methods to conduct their research: qualitative, 
quantitative, or mixed methods. The qualitative research method is the most common 
method of data collection used in healthcare research as it offers insights into behavior 
(Leung, 2015). Additionally, Pierre (2017) stated that marketing research could greatly 
benefit from using the qualitative approach. Despite the value in using the qualitative 
method to conduct healthcare marketing research, many scholars have excluded 
qualitative research results because they considered quantitative studies more objective 
(Hammarber, Kirkman, & de Lacey, 2016). However, researchers cannot quantify the 
meanings that study participants assign to their feelings of a phenomenon in question 
(Mahoney & Vanderpoel, 2015). The scope of experiences of participants is broader than 
precise, statistical generalizations using hypothesis testing, set parameters, and 
mathematical analyses (Mahoney & Vanderpoel, 2015). I selected a qualitative method 
for this case study because I intended to explore actions of behaviors regarding marketing 
products to promote sales and no numerical data or statistical analysis was required. 




The quantitative approach is focused on the systematic empirical investigation via 
statistical, mathematical, or computational methods (Creswell, 2009). Researchers use 
quantitative methods to collect and perform mathematical analyses (Bambale, 2014). 
Quantitative methods are suitable in identifying causality and correlate two or more 
variables (Hammarber et al., 2016). I did not intend on using the quantitative approach 
for this study because the goal of this study was to explore the strategies business 
development managers used for marketing NGS validation packages. I did not perform 
analyses using statistical data, and I did not present the analysis using mathematical 
interpretations. 
Researchers use the mixed methods research design by combining the qualitative 
and quantitative approach (Creswell, 2009). McKim (2015) argued that there is value in 
performing a mixed methods study because the use of multiple research methods can 
make the research more comprehensive than a single method. The combination of 
qualitative and quantitative methods involves testing theories statistically while revealing 
the behaviors and perceptions of the study participants (Morse, 2016). However, because 
I did not intend on performing statistical, mathematical, or computational analyses, I did 
not use the mixed method.  
Research Design 
I considered four qualitative research designs before choosing a case study 
design: case study, narrative, ethnographic, and phenomenological. Case study research is 
used to study an event, program, or activity (Creswell & Poth, 2017). Researchers use the 
case study design to study complex phenomena within research contexts (Yin, 2014), 
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which is a valuable method for research in health science (Leung, 2015) and marketing 
(Pierre, 2017). A case study design is suitable for exploring an issue through analysis and 
in-depth description of a bounded system (Creswell & Poth, 2017). The case study design 
was the appropriate model because the focus of this research was to understand the 
strategies used by business development managers who had successfully marketed their 
instrument validation packages. The case study design allowed me to explore the 
marketing strategies and understand the success elements within a diagnostic instrument 
manufacturing organization.  
The use of a narrative design is suitable to explore experiences of individuals that 
are expressed in lived stories (Tetnoski, 2015). The ethnographic design includes the 
description and interpretation of shared patterns of values, behaviors, beliefs, and 
language of a group (Creswell & Poth, 2017). Because the goal of this study to explore 
marketing strategies did not require analyses from lived stories or shared culture, I did 
not pursue the narrative or the ethnographic design. Phenomenological and case study 
designs are most popular for marketing research (Moller & Parvinen, 2015). The 
phenomenological design was not chosen because it is for exploring the human 
experience from the view of those who lived the phenomenon (Creswell & Poth, 2017), 
which was not the intent of this study.  
The researcher should provide more in-depth questioning to gain richness in data 
to achieve validity due to a small sample size (Marshall et al., 2015; Yin, 2014). 
Purposeful sampling can assure the requisite knowledge of the phenomenon (Palinkas et 
al., 2015) and provides possible inclusion of new perspectives to the research topic and 
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makes the results more conceptually aligned with the research purpose (Benoot, Hannes, 
& Bilsen, 2016). Therefore, I employed purposeful sampling with a sample population 
that consisted of four business development managers with comprehension of marketing 
strategies, familiarity with the compliance products and their product lifecycles, the 
autonomy to make decisions, and the track record of contribution to increasing sales in 
instrument validation packages. Although the sample size was small, I performed 
member checking, interviewed business development managers responsible for various 
product lines, and collected data from the organization’s website to obtain a 
representative glimpse into the research topic.  
Researchers reach data saturation when adequate and quality data are collected to 
support the study (Walker, 2012) and no new information or themes appear (Saunders et 
al., 2017). The researcher determines when data saturation is reached (Tran et al., 2017). I 
asked probing questions to all study partakers until there were no new ideas from the 
responses, indicating that I had achieved data saturation. 
Population and Sampling  
I considered three types of sampling approaches for this qualitative interview-
based exploratory study: snowball, quota, and purposeful sampling. Researchers use 
snowball sampling techniques to identify study participants by relying on initial 
participants to identify additional partakers (Heckathorn & Cameron, 2017). Snowball 
sampling is an effective sampling technique for identifying hidden populations (Waters, 
2015). However, snowball sampling often leads to biases because participants often 
recruit their own associates (Marcus et al., 2016). The ideal participants for this study 
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were experienced business development managers. I did not employ snowball sampling 
technique for this study because no hidden populations were required.  
Quota sampling is a nonprobability sampling strategy (Setia, 2016) that is suitable 
for studies involving more than one sample populations (Acharya, Prakash, Saxena, & 
Nigam, 2013). When conducting quota sampling, the researcher identifies variation 
categories and recruits a number of participants proportional to each category (Gorny & 
Napierala, 2016). I did not use quota sampling technique for this study because there was 
only one sampling population required for data collection.  
Researchers use purposeful sampling technique to seek out participants who cover 
the full range of specific perspectives that will contribute to the research topic (Benoot et 
al., 2016; Bungay et al., 2016). Purposeful sampling is common in qualitative research 
because this sampling method provides rich information (Palinkas et al., 2015). I 
employed purposeful sampling technique for this study because the goal of this study was 
to understand what marketing strategies successful managers used to promote NGS 
validation packages. The participants were business development managers who 
possessed marketing experience and knowledge that contributed to my research topic. 
The sampling size in a qualitative study is influenced by theoretical and practical 
considerations (Robinson, 2014). The ideal sampling size is large enough to test the 
theory reliantly while meeting the resource allocation for the study (Cleary, Horsfall, & 
Hayter, 2014). In interviews for a single case study, researchers should aim for a sample 
size that is sufficiently small for individual cases to have a locatable voice within the 
study and for an intensive analysis of each case, typically between 3-16 participants 
68 
 
(Robinson, 2014). The researcher must decide who and how many participants to include 
in a qualitative study and how to obtain knowledge from the participants for a productive 
study (Marshall et al., 2015; Morse, 2015). I decided to perform a single case study with 
a population of individuals who would satisfy the participant criteria in one organization. 
The industry and study population for this research was business development managers 
in an NGS instrument manufacturing organization located in the western United States 
who had marketed instrument validation packages aimed to help clinical customers with 
laboratory quality. For this study, I focused on a clinical diagnostic instrument 
manufacturing organization that had various types of customers in regard to the 
laboratory type, laboratory size, accreditation status, and the number of clinical tests 
performed. I established professional relationships with multiple business leaders and 
managers to enhance the research experience during the data collection phase (Raheim et 
al., 2016). The average sample population for a case study design consists of one to four 
study participants (Yin, 2014). The population of the study included four business 
development managers located in the western United States who had demonstrated 
success in the field of marketing in NGS instrument validation packages. I conducted the 
interviews in a reserved conference room in the study participants’ organization. 
There is a widespread acceptance for data saturation as a methodological principle 
in qualitative research (Saunders et al., 2017). Researchers reach data saturation when 
adequate and quality data are collected to support the study (Walker, 2012). Determining 
the point of data saturation can be difficult as researchers have information on only what 
they have collected (Tran, Porcher, Tran, & Ravaud, 2017). The decision to stop data 
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collection and when data saturation is reached is dictated by the judgement and 
experience of the researcher (Tran et al., 2017). I continued to ask probing questions to 
all study partakers until there were no new ideas from the responses, indicating that I had 
achieved data saturation.  
Ethical Research 
The written consent form not only provides information to study participants but 
also ensures confidentiality and protection of participants’ rights during the data 
collection process (Gibson, Benson, & Brand, 2013). The informed consent provides 
assurance to the research participants by stating that the participation is not deceived or 
coerced (Koonrungsesomboon et al., 2016). The informed consent supports the 
participants’ autonomy because it explains the scope of the research (Newington & 
Metcalfe, 2014). The consent process involves explaining to the participants the purpose 
of the study, how the research may contribute to the business, the procedures for 
conducting the research, and the voluntary nature of the study. The benefits and risks of 
partaking in the study will be listed in the consent form so that the participants can 
adequately evaluate the situation prior to signing the consent form. I provided the 
informed consent forms to the study participants via e-mail. Each participant replied to 
the email with the attached informed consent form and a statement of their consent.  
Christians (2011) posited that research participants should not feel compelled to 
cooperate involuntarily. Drake (2013) recommended researchers inform participants that 
they can withdraw from the study for any reasons. Angelos et al. (2017) argued that to 
conduct ethical research, the researcher should allow participants to withdraw from the 
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study without questioning. The participants for this study could withdraw without penalty 
throughout the research process by notifying the researcher via phone or email. 
Research compensation attracts participants to engage in the study (Collins et al., 
2017). Harriss and Atkinson (2014) argued that to conduct ethical research, the 
researchers must inform the participants the details of any incentives or compensation. 
Many study participants who do not foresee harm from taking part in the research are 
willing to contribute without compensation (Killawi et al., 2014). I informed my research 
participants upon recruitment that I would not compensate them for contributing in this 
study.  
To ethically protect the participants, I adhered to the Belmont protocol when 
conducting the research. There are three major components of the Belmont Report: 
Respect, beneficence, and justice (Miracle, 2016; Zucker, 2014). The respect component 
emphasizes the participants’ right to participate of not participate in the study. The 
beneficence component focuses on the researcher’s responsibility to minimize risk or 
harm to participants. The justice component concentrates on the likely benefit 
participants receive from participating in the study (Miracle, 2016). In addition, the 
Belmont Report serves as a guide to IRB deliberations to ensure that studies are 
conducted ethically (Honig, Lampel, Siegel, & Drnevich, 2014). Before commencing my 
proposal, I completed the National Institute of Health (NIH) Protecting Human Research 
Participants course to ensure that my understanding of ethical protection for my 
participants was up to date.  
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Prior to the commencement of data collection, I sought approval from Walden 
University’s IRB. After I received authorization from IRB, I contacted the qualified 
participants and conducted the research after obtaining permission from the individuals 
and their organization. I documented the study electronically. I stored the digital data on a 
computer with a password. In addition, I saved another copy of the information on an 
external hard drive in a secured safe with a combination lock for a minimum of 5 years 
before I delete the files. I included the Walden University IRB approval number 05-14-
18-0621252 on the final doctoral manuscript. 
Morse and Coulehan (2015) suggest researchers use pseudonyms to represent 
study participants and business during research to extend privacy, anonymity, confidence, 
and trust. Leibenger, Moller, Petrlic, Petrlic, and Sorge (2016) argued that using 
pseudonyms for privacy protection is important in research both technically and legally. 
Allen and Wiles (2015) posit that the use of pseudonyms to confer anonymity is more 
than a technical procedure in qualitative research because it has psychological benefits to 
both the participants and the researcher. I used pseudonyms such as Pers1 through Pers4 
to reference the four participants I interviewed for the study. I withheld the name of the 
participants from any documentation related to the study. 
Data Collection Instruments 
In qualitative research, the researcher often becomes the instrument for collecting 
data (Arriaza, Nedjat-Haiem, Lee, & Martin, 2015) because the researcher visualizes, 
records, and interprets the data (Denzin, 2014; Marshall & Rossman, 2015). I was the 
primary data collection instrument in this qualitative single case study using 
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semistructured interviews. Researchers use semistructured interviews to ascertain 
subjective responses from study participants regarding a specific situation or 
phenomenon they have experienced (McIntosh & Morse, 2015). This interview method 
includes following a detailed interview protocol or schedule and can provide reliable, 
comparable qualitative data (Jamshed, 2014). Researchers can stray from the interview 
protocol when it is appropriate in semistructured interviews, gaining opportunities for 
identifying new information to the relevant topic (Neergaard, Olesen, Andersen, & 
Sondergaard, 2009). A copy of the interview questions is available in the interview 
protocol in Appendix A. Attali, Laitusis, and Stone (2016) showed that participants 
would provide more detailed information when answering open-ended questions. There 
are eight open-ended questions contributing to the research question for the 
semistructured interviews. I followed the interview protocol in Appendix A when 
performing data collection. 
Baillie (2015) posited that using a different source to collect data provides 
reassurance to the findings. Ajagbe, Isiavwe, Sholanke, and Oke (2015) suggested 
researchers review secondary documents to support findings. Marshall and Rossman 
(2016) recommended researchers use company or archival documents as an instrument to 
collect data related to the study. Flyers are a tool for marketing to reach customer 
awareness (Ziliani & Leva, 2015). Leva, D’Attoma, Ziliani, and Gazquez-Abad (2016) 
posited that flyers are key media featuring product and brand promotions. Luceri, Latusi, 
Vergura, and Lugli (2014) suggested that the characteristics of the flyers could impact the 
product-offering organization’s performance as flyers are an avenue for organizations to 
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reach their customers. I used marketing flyers to investigate target markets, product 
offerings, and distribution channels to gain knowledge on what marketing strategies 
successful business development managers used to promote NGS instrument validation 
packages impacting their organization’s profitability. A sampler flyer is in Appendix B. 
Member checking is a technique for exploring the credibility of results as data or 
results are returned to participants to review for accuracy and quality of resonance with 
their experiences (Birt, Scott, Cavers, Campbell, & Walter, 2016). Baillie (2015) posited 
that member checking is the most crucial technique for qualitative research credibility. 
Researchers often use member checking to enhance reliability and validity (Cleary et al., 
2014). I conducted follow-up interviews after the initial data collection session to 
perform member checking and identify recurrent themes as indicated in the interview 
protocol in Appendix A.  
Data Collection Technique 
Researchers gain more relevant insights in interviews compared to other research 
methods in qualitative research (DeMassis & Kotlar, 2014). There are many ways to 
conduct interviews: telephone, Internet, or face-to-face (Petty, Thomson, & Stew, 2012). 
Mathrick, Meagher, and Norbury (2017) posited that there is importance of nonverbal 
social communication during interviews, suggesting researchers may gain additional 
insights on the research topic when performing a face-to-face interview rather than an 
over-the-phone interview. I conducted face-to-face interviews for this study with open-
ended questions.  
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I used qualitative, semistructured interviews to encourage participants in the study 
to describe their experiences with NGS instrument validation offerings, marketing 
strategies, and revenue growth. Researchers use data collection technique to 
systematically collect information regarding the research topic (Yin, 2014). There are 
advantages in conducting semistructured interviews. Participants in semistructured 
interviews answer preset open-ended questions, which is an avenue for detailed 
information (Jamshed, 2014). McIntosh and Morse (2015) and Neergaard et al. (2009) 
posited that semistructured interviews are an excellent approach for a researcher to focus 
on specific details for the research question because (a) they require the researchers to 
follow an interview protocol, which increases study reliability, and (b) they allow 
researchers to stray from the protocol when necessary, which provides opportunities to 
identify new information. I used semistructured interviews to explore strategies business 
development managers use to integrate dynamic capabilities to market NGS instrument 
validation packages. I conducted interviews to obtain detailed information regarding the 
participants’ experience and opinions regarding the research topic. Before commencing 
data collection, I submitted an IRB application to request permission from Walden 
University to conduct the study and obtain a written authorization. After receiving IRB 
approval, I contacted my research participants via email, attaching an invitation letter and 
informed consent form. The invitation letter contained the purpose and the scope of the 
study while the informed consent form covered the participants’ willingness to partake in 
the study. I asked the participants to reply I consent to my original email thread and 
attach the informed consent form. 
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I used the pre-designed open-ended semistructured interview questions to obtain 
detailed information relating to my research question, observe responses from 
participants, record the responses, and ensure the consistency with categories and themes. 
Morse and Coulehan (2014) argued that there are disadvantages with studies involving 
interviews because the participants’ relationship with the researcher can impact their 
responses. Raheim et al. (2016) suggested that the researcher’s experiences, reasoning, 
and overall impact throughout the research process can affect study participants’ 
behavior. Building rapport and study participants’ trust are critical in obtaining detailed 
data (Witty et al., 2014). I enhanced the research experience by maintaining 
professionalism throughout the interviews. Another disadvantage of interviews is that the 
participants can have verbose responses, resulting in challenges in data transcription and 
interpretation (Levit et al., 2017). McGonagle, Brown, and Schoeni (2015) suggest 
researchers record interviews to gain opportunities to transcribe the responses. Cridland, 
Jones, Caputi, and Magee (2014) also recommend researchers to record interviews for 
accurate data analysis. Anyan (2013) argued that recording the interviews allows 
researchers to focus on observing participants’ nonverbal expressions, which can lead to 
better understanding of the research topic. I recorded the interviews to ensure that the 
transcription is complete and use pseudonyms such as Pers1 through Pers4 to reference 
the study participants. 
Researchers use pilot studies to examine the feasibility of an approach (Kaae et 
al., 2016; Leon, Davis, & Kraemer, 2011). The application of pilot studies will help 
researchers identify problems related to participant recruitment and acceptability of the 
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interview protocol (Janghorban, Roudsari, & Taghipour, 2014). There are three specific 
functions of pilot studies in qualitative research: exercising epoch within the 
phenomenological study, increasing sensitivity in grounded theory, and allowing 
familiarity with fieldwork in ethnography (Janghorban et al., 2014). As a result, pilot 
studies were not applicable for this case study.  
Member checking allows researchers to improve the credibility, validity, and 
accuracy of the study as data or results are returned to participants to review for accuracy 
and resonance with their experiences (Birt et al., 2016; Cleary et al., 2014). Drisko (2016) 
recommended using member checking as a method to validate research findings and 
confirm interpretations from the interviews. Baillie (2015) argued that because member 
checking provides both the participants and the researcher an opportunity to verify 
findings, it enhances the research validity and credibility. I conducted member checking 
within 48 hours after the interviews by providing participants with a brief one paragraph 
synthesis of my interpretation to the responses to the interview questions. I asked 
participants to verify whether or not my interpretation accurately reflected their 
responses.  
Marketing flyers help raise customer awareness (Ziliani & Leva, 2015) and are 
key media for promoting products (Leva et al., 2016). Flyers often contain rich 
information regarding product offerings (Apostolova, Pourashraf, & Sack, 2015) and 
target markets (Gallo, Zamberleti, & Noce, 2015). I used marketing flyers available as 
my secondary data source. A sample marketing flyer is in Appendix B.  
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Data Organization Technique 
To capture the participants’ responses and document the intonations, I used Skype 
to conduct the interviews and record the audio. McGonagle, Brown, and Schoeni (2015) 
emphasized the benefits of recording interviews as it provides the researcher an 
opportunity to revisit the data. Anyan (2013) and Cridland et al. (2014) recommended 
researchers use interview recordings to ensure accurate interpretation of the responses. I 
examined the recordings and compared them with my notes after the interviews. Many 
researchers use NVivo 11 software to analyze research data (Woods, Paulus, Atkin, & 
Macklin, 2015). NVivo software allows researchers to compare the answers from the 
participants (Sotiriadou, Brouwers, & Le, 2014). I used NVivo 11 in conjunction with 
Microsoft Word 2010 to analyze the data. I filed my data digitally, and I used 
pseudonyms such as Pers1 through Pers4 to reference study participants and protect their 
identity. I created folders to represent different themes and placed documents associated 
with each participant in an individual folder. I stored the data files in a password-
protected computer. I saved another copy of the information on an external hard drive, 
which will be kept in a secured safe for a minimum of 5 years before I delete the files. 
Data Analysis 
I performed data analysis via thematic analysis. The purpose of thematic analysis 
is to identify patterns or themes across a dataset that will lead to an answer to the research 
question (Clarke & Braun, 2014). Good thematic analysis will enhance the 
trustworthiness of the study (Elo et al., 2014). The key characteristic of thematic analysis 
is the systematic process of coding, examining of meaning of a description through the 
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creation of theme (Vaismoradi, Jones, Turunen, & Snelgrove, 2016). The thematic 
analysis process begins with the researcher reading and understanding the data 
(Vaismoradi et al., 2016). The second step of thematic analysis involves the researcher 
creating categories of the data as key themes emerge (Vaismoradi et al., 2016). After 
categorizing the key themes, the researcher should search for similarities between 
categories and organize them into subthemes (Vaismoradi et al., 2016). I followed the 
thematic analysis steps recommended by Vaismoradi et al. (2016) when performing data 
analysis. The steps included four stages: initialization stage, construction stage, 
rectification stage, and finalization stage (Vaismoradi et al., 2016). The initialization 
stage involves the researcher reading transcriptions, coding, looking for abstractions, and 
writing notes. The construction stage involves the researcher classifying, comparing, 
labeling, defining, and describing the topics and themes. The rectification stage involves 
the researcher relating themes to establish knowledge. Lastly, the finalization stage is 
when the researcher develops the storyline and concludes the findings. 
Triangulation increases study credibility (Manganelli et al., 2014). Triangulation 
involves multiple methods in exploring the same phenomenon (Carter et al., 2014). 
Researchers performing qualitative studies often conduct methodological triangulation by 
collecting and analyzing data from multiple sources such as interviews and observations 
(Heale & Forbes, 2013). I included interviews, observation, audio recording, and the 
marketing flyers to achieve methodological triangulation in the thematic analysis. Cleary 
et al. (2014) suggested researchers use pseudonyms to conceal the identities of study 
participants during data collection, while Yin (2014) suggested the use of pseudonyms to 
79 
 
reinforce participants’ protection during data analysis. Before performing data analysis, I 
used pseudonyms to represent the business entity and the participants’ identity during the 
entire study and codes to identify major themes emerging from the interview process. I 
used pseudonyms such as Pers1 through Pers4 to reference the four study participants. 
A part of the data analysis involved transcription of the notes and recording from 
the interview during the data collection phase. NVivo is a data analysis software that 
provides structure to texts, helping researchers to sort through rich interview transcripts 
(Robins & Eisen, 2017). Some researchers prefer using Microsoft Excel as a tool to 
transcribe data (Plamondon, Bottorff, & Cole, 2015) while others prefer NVivo to sort 
and organize data (Cooper, 2017; Woods et al., 2015). I first transcribed digital data using 
Microsoft Word 2010 and then continued the data organization with NVivo 11. I 
imported interview transcripts in Microsoft Word format to NVivo software. NVivo 
software allowed me to sort my interview transcripts efficiently because my 
semistructured interviews shared a uniform format.  
During the data analysis phase, I examined the emerging themes from both digital 
and written data for consistency. I evaluated the data against the conceptual framework 
and findings from the similar studies during the process of iterating on the main themes. 
The conceptual framework for this study was dynamic capabilities by Teece et al. (1990). 
Dynamic capabilities theory drove the thematic analysis to deliver an understanding of 
the marketing strategies employed to increase NGS validation packages. Augier and 
Teece (2009) argued that due to the expansion of trade and rapid competitive responses, 
businesses need to develop and maintain asset alignment capabilities and collaborate with 
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each other to combine resources to deliver value to customers. I anticipated themes 
related to increasing product value and competitive edge to emerge. O’Connor et al. 
(2016) performed a study on medical device sales results used a similar approach. Beatty 
et al. (2016) also employed a similar approach attempting to understand customer 
expectations and the value in services. Understanding how prior studies applied dynamic 
capabilities enhanced my knowledge related to marketing strategies used by participants 
in the study.  
Reliability and Validity  
Reliability and validity are two major components of any research as they assure 
the results are as rigorous and trustworthy as possible. Qualitative researchers must avoid 
fatigue, errors of interpretation, and personal bias (Bengtsson, 2016; Noble & Smith, 
2015). It is the researchers’ responsibility to assure validity and reliability throughout the 
entire study (Cypress, 2017). 
Reliability 
In qualitative studies, reliability refers to consistency in the research outcome and 
the extent to which the research will yield the same or similar results if performed under 
the same conditions (Noble & Smith, 2015). It is the idea of replicability, repeatability, 
and stability of results or observation (Moon, Brewer, Januchowski-Hartley, Adams, & 
Blackman, 2016). In qualitative research, a thorough description of the entire research 
process that allows for inter-subjectivity indicates good quality (Cypress, 2017). 
Researchers can confirm reliability by applying consistency and care in the application of 
research practices throughout the study. 
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Dependability refers to maintaining consistency during the research process 
(Drisko, 2016). Funder et al. (2014) posit that avoiding questionable research practices by 
improving research decision transparency can increase study dependability. The audit 
trail technique refers to the researcher keeping records of all stages of their research and 
having the records available (Baillie, 2015), which helps with research transparency and 
dependability. Researchers should document research design and implementation, 
including the methods and details of data collection to increase dependability (Moon et 
al., 2016). I kept an audit trail by documenting the order of the data analysis, 
organization, and process. Drisko (2016) recommended researchers use triangulation and 
dependability audit to ensure dependability of data. I transcribed, documented, and 
analyzed the data as accurately as possible to achieve dependability. I transcribed the 
recorded interviews verbatim and paraphrased where necessary. Member checking is a 
technique for researchers to return the results to the participants to check for accuracy 
(Birt et al., 2016). Ballie (2015) argued that member checking is critical for qualitative 
research credibility while Cleary et al. (2014) posited that member checking would 
enhance study reliability and validity. To avoid inaccuracies, I used member checking to 
perform data validation and ensure that I accurately recorded the participants’ response.  
Validity 
Validity ensures that the presentation of results truthfully reflect the phenomena 
studied (Bengtsson, 2016). A valid study should precisely demonstrate the themes as 
validity in research is concerned with the accuracy and truthfulness of the findings 
(Cypress, 2017). Researchers conduct credibility, transferability, and confirmability tests 
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to enhance validity in their studies (Noble & Smith, 2015). In addition, researchers often 
use member checking to improve validity (Cleary et al., 2014). I validated the results of 
the study by conducting applicability, consistency, and neutrality tests. 
Creditability refers to tests performed to ensure research findings are accurate and 
truthful (Marshall & Rossman, 2015). I used protocols amid the research and interview 
process. Additionally, I identified and recorded recurrent themes by asking iterative 
questions, performing data triangulation, and using peer scrutiny to achieve creditability 
during the research process. Drisko (2016) suggested using member checking as a mean 
to validate research findings and interpretations from the interviews. Baillie (2015) 
recommends researchers to use member checking as a technique for credibility in 
qualitative research. Cleary et al. (2014) suggest that member checking enhances study 
reliability and validity because it provides the participants an opportunity to verify data 
accuracy. I performed member checking after conducting interviews with four business 
development managers by providing the participants my interpretation of the data 
collected in our initial interview for validation. The open-ended semistructured questions 
provided study participants flexibility and opportunity to share detailed information 
regarding strategies for marketing NGS instrument validation packages. Yin (2014) 
recommended using triangulation to increase research quality. Triangulation involves 
multiple methods in exploring the same phenomenon (Carter et al., 2014). Researchers 
performing qualitative studies often conduct methodological triangulation by collecting 
and analyzing data from multiple sources such as interviews and observations (Heale & 
Forbes, 2013). I performed triangulation by cross-checking the data obtained from the 
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interviews and analyzing the contents of marketing flyers to confirm that I had covered 
all aspects of the research question thoroughly.  
Transferability refers to the extent to which a study is applicable in other contexts 
and environments (Drisko, 2016). Purposeful sampling not only involves selecting 
individuals that are especially knowledgeable about or experienced with a phenomenon 
of interest but also ensures the participants’ availability and willingness to participate 
(Marshall & Rossman, 2016). Benoot et al. (2016) posit that purposeful sampling 
provides possible inclusion of new perspectives to the research topic and makes the 
results more conceptually aligned with the research purpose. Leung (2015) argued that 
purposeful sampling increases the ease of respondent verification because it is concept-
oriented. I employed purposeful sampling to construct my research to gain a 
comprehensive understanding of all the studies that met the same pre-determined criteria 
to enhance transferability.  
Confirmability refers to the degree to which the results can be confirmed or 
corroborated by others (Drisko, 2016; Noble & Smith, 2015). Confirmability of research 
findings through recorded evidence allows researcher reviewers to logically follow to the 
conclusions (El Hussein, Jakubec, & Osuji, 2016). The researcher can increase 
confirmability of the study by documenting the procedures for checking and rechecking 
the data (Thomas & Magilvy, 2011). I documented the procedures for examining the data 
throughout the study to achieve confirmability. In addition, I documented how I 
identified emerging themes from the data as recommended by Moon et al. (2016) to 
avoid potential bias and enhance study confirmability. 
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Reaching data saturation occurs when there is enough information to replicate the 
study, when the ability to obtain additional new information has been attained, and when 
further exploration is no longer feasible (Fusch & Ness, 2015). Researchers reach data 
saturation when adequate and quality data are collected to support the study (Hagaman & 
Wutich, 2016) and no new information or themes appear (Saunders et al., 2017). Failure 
to reach data saturation hampers content validity. I interviewed four business 
development managers who had successfully marketed NGS instrument validation 
packages in the western United States. I intended on recruiting additional study 
participants if new themes from data and ideas continued to emerge. I reached data 
saturation when themes from data became familiar and no new information was 
available. 
Transition and Summary 
Section 2 includes the purpose statement, role of the researcher, study 
participants, research methodology and design, population and sampling, ethical research, 
data collection, data organization, data analysis, and reliability and validity. These 
sections help describe and justify the study design. The goal of this study was to explore 
what strategies successful managers used in promoting NGS instrument validation 
packages. I performed a qualitative case study. I functioned as an investigator in the data 
collection process and abide by the IRB guidelines. I utilized my professional experience 
as a product manager in a clinical instrument manufacturing organization to recruit and 
maintain working relationships with the eligible participants. I protected the participants 
by adhering to the Belmont Report ethical guidelines. I provided the participants with an 
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informed consent form detailing the scope of the study. The participants were not 
compensated and were free to withdraw from the study. I used an interview protocol to 
avoid bias and standardize the interview process. I employed purposeful sampling to 
recruit participants with knowledge and experience related to marketing instrument 
validation packages. I planned on interviewing at least 4 business development managers 
from an oncology diagnostic instrument manufacturing organization for data collection. I 
intended on recruiting more participants until I reached data saturation where no new 
themes emerged. I performed a follow-up interview with the participants to perform 
member checking, enhancing validity. I used interviews, observation, audio recording, 
and marketing flyers to achieve methodological triangulation. I will preserve data in a 
secure location for five years. I will destroy the files after five years. 
Section 3 will contain the research findings, application to professional practice, 
implications for social change, recommendations for action and future research, 
reflection, and a conclusion. This section will provide detailed information describing 
how and why successful marketing managers in an oncology diagnostic instrument 
manufacturing organization incorporated dynamic capabilities to achieve sustainable 
revenue growth. Interpretation of the findings will highlight potential transferability of 
the results for applications in professional practice. Additionally, I will present the 




Section 3: Application to Professional Practice and Implications for Change 
The purpose of this qualitative exploratory single case study was to explore 
strategies business development managers used to integrate dynamic capabilities for 
marketing instrument validation packages aimed to increase clinical laboratory quality 
and test accuracy. From the interviews with business development managers of a NGS 
manufacturing organization in the western United States, I identified one overarching 
theme and four subthemes. The overarching theme was collaboration of cross-functional 
teams. The four subthemes included integration, effectiveness, partnership, and 
profitability. Results from this study show that collaboration of cross-functional teams 
was the most common element from the data collected. Section 3 includes presentation of 
my findings, discussion of applications for professional practice and implications for 
social change, recommendations for actions and future research, my reflections, and the 
conclusion to the study. 
Presentation of the Findings 
The overarching research question of this study was: What marketing strategies 
do managers in oncology diagnostic instrument manufacturing organizations use to 
promote instrument validation packages for increasing the accuracy of oncology 
laboratory test results. One overarching theme (collaboration of cross-functional teams) 




Overarching Theme: Collaboration of Cross-Functional Teams 
Collaboration of cross-functional teams was the primary theme that emerged from 
the interviews with business development managers. In their responses to Interview 
Questions 3, 5, and 6, Pers1 through Pers4 indicated that the collaboration of cross-
functional teams was key for the deployment of successful marketing strategies for 
instrument validation services. This theme is supported by previous researchers such as 
Salvato and Vassolo (2017), who argued that organizations that can integrate internal and 
external resources are more capable to compete in rapidly changing business 
environments. Szalavetz (2015) also posited that the relationship and reconfiguration of 
organizational internal structures could increase organizational competence. Additionally, 
Rosch and Schumacher (2018) showed that integration increased organizational 
flexibility, which can contribute to economic success (Kaleka & Morgan, 2017). The 
collaboration of cross-functional teams allowed the organization to obtain customer 
feedback and information regarding potential target markets quickly, aiding business 
development managers in creating strategies and objectives to gain positive results. 
Successful marketing strategies from business development managers are 
dependent on the knowledge and experience of the managers and their interaction with 
their cross-functional teams. For example, Pers2 explained, 
many of our customers were not aware of the validation products that we offered, 
and they were not sure if the specific workflow that required validation could be 
included in the package. Our field service engineers who performed the 
installation of the customers’ instruments often let the validation development 
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team know exactly what the customers were looking for, and then we distributed 
product information specifically for that particular customer needs.  
Resources by themselves are not always sufficient to create value for 
organizations in competitive environment (Zhang & Wu, 2017). An organization’s ability 
to deploy resources internally is more important than the amount of resources itself (Jeng 
& Pak, 2016). The marketing strategies using the collaboration of cross-functional teams 
helped sell NGS instrument validation packages according to all study participants. For 
example, Pers3 stated, “our customer-facing staff often build great relationships with our 
customers and because of the trust that our customers have for our field engineers, our 
validation packages practically sell themselves.” This statement is consistent with the 
findings by Dang et al. (2014) that customer perception is key in clinical settings. 
O’Connor et al. (2016) also suggested that customer-facing representatives’ relationship 
with the client can influence purchase choices. 
As the business world becomes interconnected, organizations should not ignore 
the power of collaboration (Trajkovic & Milosevic, 2016), which can help in creating a 
strong culture in quality that helps create product value (Powell et al., 2013). Pers3 
mentioned that in instrument validation industry, the goal is to provide documented proof 
that an instrument or device in a workflow is performing to the manufacturer’s 
specifications. Therefore, the documentation provided by these services must be of 
quality. The business development managers work with the research and development 
teams to gain knowledge of a comprehensive instrument performance profile. With the 
understanding of instrument capabilities, the acceptable performance range is established. 
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In addition to working with the research and development teams, these business 
development managers frequently consult with the legal and quality teams to ensure that 
a formal documentation style is present to support their customers’ quality systems. 
These actions support the argument that (a) producing instrument validation packages are 
a collaborated effort and (b) to successfully market a product, it must resonate with the 
customers’ needs. 
The literature in Section 1 relating to an organization’s dynamic capabilities and 
how single-dimensional resources by themselves are not sufficient to create value in 
competitive environments (Zhang & Wu, 2017) coincides with the overarching theme 
that emerged from this study. The contribution from cross-functional teams cannot be 
overlooked in marketing NGS instrument validation services aimed to improve clinical 
diagnostic quality. The findings confirm the results in literature review: through 
collaboration and combination of resources, organizations gain dynamic capabilities that 
lead to competitive advantage. 
Subtheme 1: Integration 
Dynamic capabilities determine organizations’ ability to build, integrate, and 
realign internal and external resources (Teece, 2010). Marketing dynamic capability 
refers to the organization’s ability to increase the value of its products and services while 
differentiating them from those of its competitors (Jeng & Pak, 2010). When comparing 
different manufacturing organizations, customers make purchasing choices based on 
resources, infrastructure, experience, and applications available (Quail et al., 2012). In 
response to Interview Question 3 regarding the marketing strategies participants used for 
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NGS instrument validation packages, all participants said product integration played a 
key role. All the participants reported that although there was a dedicated marketing and 
sales team for validation products, targeting revenue generation, product integration was 
a major dealmaker for the NGS customers. Many clinical customers look for an end-to-
end solution. Therefore, there is value in offering compliance packages starting from 
sample preparation to results verification. Pers2 shared an experience regarding a 
customer who purchased their competitor’s instrument platform, but the competitor was 
not able to provide validations for the entire workflow. While exploring other options, 
this customer found out that Pers2’s organization offered an end-to-end solution. In the 
end, the customer returned the competitor’s products and bought the instruments from 
Pers2’s organization instead, including the validation services. 
Pers1, Pers2, and Pers3 stated unanimously that product integration provided 
customers a convenient solution that is cost effective. Pers3 explained in detail, 
an analytical validation service reduces the time to develop and launch a panel 
service, reduces the cost and resource investment to develop and launch a 
diagnostic panel, and facilitates global compliance with industry standards and 
template documentation. 
Pers2 and Pers4 reported experiences with customers trying to tackle validations 
themselves but turned to purchasing the validation services offered by the organization 
instead because either the customers’ “home-brewed” methods were not up to regulatory 
standards or the cost to complete the validation soared due to inexperience and operating 
mistakes. The findings suggest that integrating product offerings within an organization 
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helps market individual products. According to all the participants, integrating instrument 
hardware, reagent, consumables, and validation services helped convince the customers 
to purchase as many customers were looking for convenient end-to-end solutions. The 
conceptual framework for this study, dynamic capabilities (Teece, 2010), where resource 
integration increase an organization’s competitive advantage, is consistent with the 
results of my study.  
All participants gave examples of marketing strategies involving product 
integration. Pers1 and Pers2 stated that internally, they have classified customer accounts 
by their instrument base. Depending on what instruments the customers owned, different 
targeted marketing collateral would be emailed to the customers. This marketing strategy 
integrates information with hardware purchase records. In addition, according to Pers1, 
the managers in the organization “purchased lists of targeted clientele from clinical 
publications or clinical lists” so the marketing team could target potential customers by 
knowing specifically what type of clinical work is performed in the customer laboratory. 
This strategy integrates information with applications records. Pers1, Pers3, and Pers4 
shared that there is an online, search engine marketing system in place along with digital 
banners, targeting customers purchasing specific chemistry kits as some chemistry kits 
suggested clinical diagnostic work was involved. This strategy integrates information 
with chemistry types. Pers4 stated that the teams in the organization used a cross-sell 
strategy for customers who purchased an assay or instrument that was compatible. 
Strategies to cross-sell included co-promoting products, pricing products in bundles, and 
placing products in the same marketing material and position them as complementary. 
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Additionally, according to Pers1 and the marketing flyers collected, there are 
marketing activities integrating service activities. For example, Per1 explained, 
the details for recent service visits can tell us if a customer is looking to switch 
from research and development phase to clinical setting, which is usually a sign 
that they will be performing some kind of validation soon.   
These participant responses are also supported by previous research. For example, 
Xavier, Jacobi, and Turra (2018) posited that integration of different knowledge and 
information often led to mutual benefits. Integration of products and services can increase 
customer loyalty and satisfaction (Kasiri, Cheng, Sambasivan, & Sidin, 2017). 
Additionally, Gebauer, Saul, Haldimann, and Gustafsson (2017) showed that marketing 
strategies integrating hardware and services helped companies achieve competitive 
advantages. These findings are consistent with the results of my study that successful 
marketing strategies often involve integration. 
Subtheme 2: Effectiveness 
The second subtheme within this study was effectiveness. The need for assurance 
in quality, cost reduction, and regulation compliance has brought increased focus on 
validation in clinical diagnostic industry (Vijayasree et al., 2017). Diagnostic instrument 
manufacturing organizations are not just providers for the equipment but also facilitators 
in quality management (Fleming, 2015). Pers1 stated, “three things are always on the 
table when customers in diagnostic laboratories consider validations: time, cost, and 
compliance. And we often focus on these three things when we market our packages.” 
Time is indicated by whether the field staff from the instrument manufacturing 
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organization can get the customers running quickly as opposed to them attempting to do 
all the validation work on their own. Pers1 indicated, “our compliance packages are 
designed to demonstrate efficiency, especially when customers run into problems 
validating on their own.” Cost is also important because when customers try to do 
validation themselves, often the process exceeds the costs of purchasing services from the 
instrument manufacturing organization. Compliance is indicated, as Pers1 articulated, by 
how “our customers have the comfortability knowing that we have performed validations 
multiple times. Our products have been audited in other laboratories without issues and 
our team members who execute validation services produce high quality documents that 
meet regulatory needs.” 
Pers3 shared comparable insights and explained, “one element that resonates with 
most customers is the fact our organization is the manufacturer of record for the 
instrument systems.” The manufacturing organization is familiar with the designs and the 
qualification protocols reflect that knowledge with a comprehensive performance profile. 
This significantly reduces the burden of development on behalf of the customers and their 
quality system, allowing them to focus on more important tasks. In addition, the formal 
documentation style that the instrument manufacturing organization often includes in 
their packages supports good quality systems. 
Confirmation from the literature review regarding NGS customers’ purchasing 
choice supports the study participants’ statements. For example, Quail et al. (2012) 
compared NGS platforms across major manufacturing organizations and found that 
customers made purchasing choices based on experience, finances, and applications. 
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Robin (2018) also posited that price, performance, and quality of products contribute to 
the value of medical devices. As regulatory requirements for clinical laboratories are 
getting more stringent, required clinical validation and methods can be costly (McMillan, 
2016). Marketing instrument validation packages with an emphasis on saving time, 
reducing cost, and gaining efficiency can lead to success.  
Compliance, as indicated by the literature review, is shown through three types of 
process validation according to the requirements stipulated by the FDA: prospective 
process validation, concurrent process validation, and retrospective process validation 
(Vijayasree et al., 2017). These process validations all entail documented evidence. 
Because quality has become a critical measure of performance and customer satisfaction, 
accreditation becomes an opportunity for laboratories to reassure their customers 
(Manickam & Ankanagarl, 2015). Powell et al. (2013) argued that by developing a strong 
culture in quality, including risk-based verification steps throughout the safety system, 
manufacturing organizations can help find a more cost-effective way to provide an 
objective value. As Pers1 explained, “when marketing, we focus on comfortability. Our 
customers know our products can survive strict audits and we are there to help them pass 
scrutiny.”  
Subtheme 3: Partnership 
Dynamic capabilities allow organizations to integrate, build, and reconfigure 
internal and external resources (Salvato & Vassolo, 2017) because resources by 
themselves are not sufficient to create value for organizations in competitive 
environments (Zhang & Wu, 2017). Jeng and Pak (2016) suggested organizations 
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combine both internal and external resources to predict changes in customer preferences 
and gain competitive advantage. For Interview Question 3, marketing strategies used for 
compliance products, and Interview Question 6, distribution channels, Pers1, Pers2, and 
Pers4 indicated that their marketing scheme would not have been successful without the 
internal and external partnerships. Pers1 stated, “internally, our sales teams often help us 
identify potential customers.” The sales teams include hardware sales teams, service 
warranty and contract sales teams, as well as consumables sales teams. These people are 
upfront sales teams that interact with the customers directly. The direct interaction with 
the customers allows the sales teams to understand their customers’ needs. Based on the 
customers’ requests, the sales teams can help the organization push for validation 
services that are tailored for the specific needs. Additionally, field service teams and field 
support teams also play an important role in marketing validation products because they 
interact with their customers at the very beginning, when the customer gets their 
instrument installed. Pers1 explained, “because of the early interaction, the customers 
tend to trust the service and support team members.”    
Pers2 concurred with the statement from Pers1 regarding internal partnerships and 
added, “our clinical applications consultants often bring leads back to the dedicated 
compliance sales and marketing team.” The clinical applications consultants work with 
their customers on the diagnostic panels as well as help customers figure out the most 
suitable chemistry for the tests. Their job functions allow them to understand the specific 
workflow that the customer needs validation for and the timelines required for the 
validation. According to Pers2, the specific workflow and the validation timelines were 
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key information required to successfully promote compliance products as they provided 
the marketing teams an avenue to perform targeted marketing.  
Externally, Pers1 stated that the team partnered with CAP and CLIA to design the 
compliance service package to attract target market. Both CAP and CLIA require clinical 
laboratories to verify performance characteristics, especially when introducing an 
unmodified approved test system, such as a medical diagnostic instrument. To comply 
with these requirements, periodic calibration and calibration verification should be 
performed (Killeen et al., 2014). Complying with clinical requirements helps make good 
medical decisions, and there is value in having periodic calibration and verification 
performed on diagnostic instruments (Ferreira-Gonzalez et al., 2014). Pers1 and Pers4 
posited that the partnership with CAP and CLIA helped market the validation packages 
because the customers trust that contents in the packages would satisfy quality standards 
required by the regulatory agencies. 
From the literature review, Trajkovic and Milosevic (2016) posited that economic, 
technical and policy standardization all play a role in helping business organization 
achieve goals. Partnership with internal teams and external organizations, such as CAP 
and CLIA, not only allows the employees in this NGS instrument manufacturing 
organization to standardize the technical and quality knowledge for their customers, but 
also facilitates business goals for both the manufacturing organization and the clinical 
laboratories. Pers1and Pers4 revealed that the enhanced partnership had improved their 
revenue in validation packages year after year. The findings support the conceptual 
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framework: combining internal and external resources increases an organization’s 
dynamic capabilities and competitive advantage.   
Subtheme 4: Profitability 
Dynamic capabilities allow organizations to combine utilization of tangible and 
intangible assets and convert them into a stream of profits (Teece, 2017). According to 
O’Connor et al. (2016), there are relationships between clinical laboratory staff and 
representatives from instrument manufacturing organizations that impact profitability. 
The interaction between the two parties can directly affect sales as close relationships 
often lead to better sales results (O’Connor et al., 2016). Pers1 and Pers4 suggested that 
using field service and support teams to market instrument validation packages was 
effective because the field staff interacted directly with the customers for their daily 
tasks. They built “a trusting relationship with the customers and the customers relied on 
their recommendations,” according to Pers1. Ind (2017) posited that customer facing 
employees should be part of marketing strategies because their interactions with the 
customers assist corporate branding and set the foundation for profitability. My findings 
aligned with Ind’s study (2017).  
Pers3 posited that the validation packages reduce the cost and resource investment 
to develop and launch a clinical panel from customers in laboratories, which led to 
indirect profitability for the customers. Pers4 concurred with Pers3 statement above, 
stating that it normally cost customers more to attempt instrument validations compared 
to purchasing a service package directly from the instrument manufacturing organization. 
In the literature review, Lyon et al. (2015) posit that validations take days to weeks to 
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complete, and the costs associated with validations are not trivial. The findings are 
consistent with the results from Lyon et al. (2015). Good laboratory practices improve 
laboratories’ competitive edge and market share because these practices increase test 
efficiency (Manickam & Ankanagarl, 2015). Vijayasree et al. (2017) stated that testing 
quality and efficiency help clinical laboratories reduce costs. The findings support 
previous studies that there is financial value in purchasing validation packages from 
instrument manufacturing organizations. Finally, for the instrument manufacturing 
organization, there is profit margin for performing validation services. Successful 
marketing strategies that promote the sales of validation packages will have positive 
impact on the financial goals.      
Applications to Professional Practice 
The strategies highlighted in this study for marketing NGS instrument validation 
packages might help business managers improve profitability across any clinical 
business. The objective of the study was to explore the strategies successful business 
development managers used to integrate dynamic capabilities for marketing instrument 
validation packages aimed to increase clinical laboratory quality and test accuracy. 
Findings of the study are valuable to leaders in diagnostic instrument manufacturing 
organizations and other third-party clinical service providers seeking to understand and 
use strategies for integrating dynamic capabilities for marketing validation services. The 
results of the study may also help managers in clinical laboratories gain a better 
understanding of good laboratory practices, which may help them detect why the 
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validation packages were designed and offered and how these packages can impact 
clinical operations. 
Cross-functional team collaboration in marketing has positive impacts on market 
orientation and business performance (Claro & Ramos, 2018). The marketing strategies 
involving internal cross-functional teams, including sales, field support, research and 
development, legal, and quality teams were successfully used by all four participants in 
the study. Bai, Feng, Yue, and Feng (2017) suggested, in the era of global competition, 
cross-functional collaboration is one of the most important keys of successful product 
implementation. Swanson, Jin, Fawcett, and Fawcett (2017) posited that modern 
organizations require dynamic capabilities to succeed and overcome powerful limiting 
conditions. Collaboration of cross-functional teams within the organization facilitates 
value creation by increasing the organization’s dynamic capabilities. Having a great 
product is important. However, to market the correct products to the customers in need 
requires joint efforts from various teams.  
An organization’s ability to increase the value of its products and services while 
differentiating them from those of its competitors is critical in today’s business 
environment (Jing & Pak, 2010). Integration of products and services often increase 
customer loyalty and satisfaction (Kasiri et al., 2017). According to the study 
participants, clinical customers sought end-to-end solutions. Therefore, integrating 
product offerings, from instrument hardware, reagent, consumables, to validation 
services, within their organization helped market individual products. Customer data 
integration can reveal the product that the customers might need (Deriyenko, Hartkopp, 
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& Mattfeld, 2017). There is strategic value in integration of relationship-oriented big data 
(Kitchens, Dobolyi, Li, & Abbasi, 2018). Business managers may incorporate customer 
data from various sources, for example, online purchase records, equipment history, and 
product interests, to market specific products and services. 
Price, performance, and quality contribute to the value of medical devices (Robin, 
2018). Clinical validation required by regulatory agencies can be costly (McMillan, 
2016). Diagnostics instrument manufacturing organizations are the providers for the 
hardware and facilitators in quality management (Fleming, 2015). All four of the 
participants indicated that being able to execute validation services efficiently while 
producing high quality documentation that meets regulatory requirement was a major 
marketing emphasis. The effectiveness of the validation packages, a function of time, 
cost, and compliance, determines the value for the customers. When developing 
marketing strategies, business managers should consider factors what would contribute to 
the value of the products. 
Resources by themselves are not sufficient to create value for organizations in 
competitive environments (Zhang & Wu, 2017). When managers in organizations 
combine both internal and external resources, they can predict changes in customer 
preferences and gain competitive advantage (Jeng & Pak, 2016). Aside from 
collaborating with internal cross-functional teams to develop and market validation 
services whenever possible, the participants in the study indicated that they partnered 
with external regulatory agencies to design the packages so the contents can be attractive 
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to target market. The findings suggest that partnership with external organizations may 
increase marketing effectiveness.   
Customer satisfaction, service quality, and loyalty can impact customer behavior 
and customer profitability (Petersen, Kumar, Polo, & Sese, 2017). Participants in this 
study suggested that promoting validation packages via customer-facing staff was 
effective because the field staff interacted directly with the customers daily. In addition to 
using customer-facing staff as a marketing channel, participants had used profitability as 
a promoter. Validations take days to weeks to complete, and the costs associated with 
validations are not trivial (Lyon et al., 2015). Having a professional service team perform 
validations has the potential to reduce laboratory down time as the specialized service 
providers are often more efficient in validation execution. The reduction of down time 
increases the laboratory’s profitability. When marketing clinical compliance services, 
business managers should consider highlighting the financial gain as an incentive to the 
customers. 
Implications for Social Change 
The results of the study contribute to social change by providing information on 
strategies for marketing and promoting oncology diagnostic instrument validation 
packages aimed to improve laboratory quality. Diagnostic laboratory results are involved 
for making medical decisions (Peter et al., 2010) and the laboratories’ operating quality 
directly impacts the accuracy of tests and patient safety (Allen, 2013). Accreditation and 
validation have the potential to improve the quality of healthcare for patients through 
reduction of testing errors and inappropriate treatment (Peter et al., 2010). The marketing 
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strategies explored in this study may help managers in instrument manufacturing 
organizations promote validation packages to clinical laboratories and raise awareness of 
meeting regulatory requirements. In addition, the findings of the study provided insights 
on solutions to minimize the cost of implementing laboratory quality systems and 
develop a standard for better laboratory practice that would lead to safer healthcare.  
Recommendations for Action 
Findings and recommendations from this study may apply to any business 
manager considering strategies for marketing clinical instrument validation packages 
aimed to improve laboratory quality. Resources by themselves might not be sufficient to 
create advantage in rapidly changing and competitive environments (Zhang & Wu, 
2017). This study highlights how collaboration of cross-functional teams, both internally 
and externally, can increase instrument manufacturing organizations’ dynamic 
capabilities, generate marketing success, and profitability for the clinical customers. 
Dynamic capabilities enable organizations to increase the value of products and 
services while differentiating them from those of its competitors (Jeng & Pak, 2010). In 
situations where clinical customers are looking for end-to-end validation solutions, 
business development managers should cross-sell, bundling and integrating instrument 
hardware, reagent, consumables, and validation services to offer a competitive and 
convenient solution. This strategy not only has the potential to secure market share, but 
also provides the customers with most confidence in validation as the same 
manufacturing organization is responsible for the entire workflow. 
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External partnership should not be overlooked in marketing instrument validation 
services. Both CAP and CLIA require clinical laboratories to verify performance 
characteristics, especially when introducing an unmodified approved test system, such as 
a medical diagnostic instrument (Killeen et al., 2014). Since CAP and CLIA publish 
checklists for clinical laboratories to comply with the requirements, partnering with CAP 
and CLIA can increase the value in validation packages as customers trust that the 
contents in the packages would satisfy quality standards stipulated by the regulatory 
agencies. 
Utilizing the relationship between the customer-facing staff and customers can 
contribute to profitability. Marketing strategies should involve training customer-facing 
staff to promote validation packages as the staff interacts directly with the customers on a 
daily basis. The customer-facing staff understand the specific workflow that the customer 
performs and the timelines when the customer would require validations. When 
marketing instrument validation packages, business managers should recruit assistance 
from field employees. 
Recommendations for Further Research 
Marshall and Rossman (2016) stated that limitations are constraints beyond the 
researcher’s control. The primary limitation of the study was what effects the relationship 
between the clinical laboratory and the compliance performance had on the success or 
failure of an accreditation or audit. If the laboratory managers opted to have the 
instrument manufacturers to perform compliance services, the results and documentation 
quality would rely heavily on the manufacturer representative who performed the tests. I 
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had not taken account for the manufacturer representatives’ relationship with the clinical 
customers nor their ability to execute validation packages. Future research should be 
conducted to explore the marketing impact associated with the manufacturer-customer 
relationship and the representatives’ technical aptitude. Additionally, the geographical 
area was limited to the western United States. Future researchers should perform a study 
on a larger geographical area and compare the data collected from this study.  
This study did not differentiate customer types. According to Pers1, validation 
packages are designed for a variety of customer bases, for example, customers running 
clinical samples in a regulated space, pharmaceutical companies running under good 
manufacturing practice, and diagnostic laboratories focusing on cancer targets. Future 
studies could address the limitations of this study by exploring marketing impact on 
different customer segments. The findings accounting for various customer types would 
add to the knowledge base of strategies for target marketing.  
Reflections 
The goal of this study was to understand how successful business development 
managers market products and services aimed to improve patient care. I found the 
doctoral study process challenging but rewarding. As a previous field service engineer for 
diagnostic instrument organizations, I had been asked to promote the validation packages 
whenever possible. However, without marketing training and the understanding of the 
impact of clinical validations, I struggled to help my customers find solutions to their 
needs. My knowledge of clinical validations was limited to the contents in the validation 
documentation and I was interested to learn the elements critical to generating marketing 
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success. My findings from this study demonstrated the significance of collaboration, both 
internal and external, contributes to marketing success that leads to closing sales. 
Prior to conducting the research, my objective was to find ways in which 
marketing managers could use dynamic capabilities to increase the sales of diagnostic 
validation packages. I had believed that convincing clinical customers to purchase 
validation packages not only contribute to instrument manufacturing organizations’ 
profits but also increase customers’ laboratory efficiency. After conducting the research, I 
concluded that successful marketing strategies are a collaboration of cross-functional 
teams. The literature review confirmed my belief that the implementation of accreditation 
and validation has the potential to improve laboratory quality, leading to better 
healthcare. This study has broadened my understanding of instrument validation 
packages, their impact in clinical settings, and the importance of internal and external 
collaboration.   
Conclusion 
The purpose of this single case study was to explore successful marketing 
strategies managers in a diagnostic instrument manufacturing organization use to promote 
sales of validation packages for increasing the accuracy of oncology laboratory test 
results. Instrument validation compliance assures that the workflow is developed, 
maintained, and operated as designed (Agnihotri et al., 2013), minimizing false diagnoses 
(Fitzgibbons et al., 2014). By promoting and marketing instrument validation packages, 
diagnostic instrument manufacturing organizations can help promote laboratory quality 
and efficiency.  
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Dynamic capabilities allow organizations to integrate and reconfigure resources to 
increase competitive edge (Teece, 2012). Dynamic capabilities also enable organizations 
to combine tangible and intangible assets and convert them to profits (Teece, 2017). 
Through continuous integration and collaboration internally and externally, business 
development managers were able to promote NGS instrument validation packages with 
success. Integration of products and services can increase customer loyalty and 
satisfaction (Kasiri et al., 2017) and marketing strategies integrating hardware and 
services may help companies achieve competitive advantages (Gebauer et al., 2017). To 
achieve profitability, diagnostic instrument manufacturing organizations should not 
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Appendix A: Interview Protocol 
What I will do What I will say – the script 
Start with Script – Introduce the interview 
and set the stage: e.g. in a single-person 
conference room to produce quality 
recording. 
• Collect signed consent forms  
• Use audio recording applications 
on my laptop and brief note taking 
 
Thank you for agreeing to participate in 
this study. My name is Hsiao-Ching 
“Sandra” Teng and I am a graduate 
student at Walden University. 
 
You were invited to participate in this 
study because you are a senior level 
manager, marketing manager, or business 
development manager in your 
organization who makes decisions 
associated with marketing strategies for 
promoting clinical diagnostic instrument 
validation. 
 
The interview will last between 30 to 45 
minutes. During this time, I will ask you a 
few questions. The purpose of this study is 
to explore what marketing strategies 
successful managers in a diagnostic 
instrument manufacturing organization 
use to promote sales in validation 
packages for increasing the accuracy of 
oncology laboratory test results. The focus 
of this study is not to evaluate your 
experiences or techniques. 
 
I would like to audio record this discourse 
today using my laptop to extend my note 
taking. Please let me know if this is okay 
with you. If so, please read and sign the 
consent form. This interview is 
confidential, and you are free to withdraw 
from the study at any time. I am the only 
person who will have access to this 
recording. All the data associated with this 
study that I will collect as well as the 
recording will be destroyed after 5 years. 
Please feel free to ask any questions at any 
time. If you do not have any questions at 




What I will do What I will say – the script 
• Identify non-verbal queues 
• Paraphrase as required 
• Ask follow-up questions to probe 
for more detailed or in-depth 
information 
1. Describe the validation packages that 
you offer for your NGS platforms.  
2. Describe the target customer base for 
the compliance products that you offer.  
3. What are your marketing strategies for 
the compliance products? 
4. What elements of the validation 
package provide a competitive 
advantage to your company? 
5. How often does your organization 
revise the compliance service package 
to reflect customer needs and attract 
target market? 
6. How does your organization evaluate 
the distribution channels for the 
validation packages? 
7. How does your organization determine 
the effectiveness of your marketing 
strategies? 
8. What additional information can you 
share regarding marketing strategies for 
promoting sales of instrument 
validation products? 
End interview with script: Let participant 
know how I will proceed from here and 
what to expect after the interview. 
Thank you again for allowing me to 
interview you today. Your perspective 
was very helpful in understanding how 
successful marketing strategies can 
promote clinical diagnostic instrument 
validation. I will synthesize your 
responses and schedule a follow-up 
interview in the next few days for you to 
verify the data and review my 
interpretations. 
Schedule member checking interview that 
will take place in the next 5 days. 






What I will do What I will say – the script 
Member Checking Follow-up Interview 
Introduce follow-up interview Great to see you again and thank you for 
taking the time. As stated during our last 
interview, the purpose of this follow-up 
interview is to ensure that I interpreted 
your responses accurately. This interview 
will last no longer than 20 minutes. Please 
let me know if you have any questions. If 
not, let us begin. 
Provide participant a copy of the 
synthesized individual questions. 
 
I will follow IRB guidelines. I will go 
through each question, provide my 
interpretation and ask the following: Have 
I covered all the information? Is there 
anything you would like to add? 
These are the questions and synthesis of 
interpretations. Pease feel free to elaborate 
of change as necessary. 
 
• Question 1 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
• Question 2 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
•  Question 3 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
• Question 4 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
• Question 5 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
• Question 6 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
• Question 7 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
• Question 8 and succinct synthesis 
of interpretation in 1 paragraph or 
more if required 
 
Provide participant with a copy of 
research results 
Thank you again. I will provide you with 





Appendix B: Sample Flyer Distributed by an NGS Manufacturing Organization 
 
